<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font17">multiple </span>
   <span class="font16">University </span>
   <span class="font16">United </span>
   <span class="font16">sclerosis </span>
   <span class="font15">disease </span>
   <span class="font15">Background: </span>
   <span class="font15">Conclusions: </span>
   <span class="font15">Methods: </span>
   <span class="font15">Objectives: </span>
   <span class="font15">Results: </span>
   <span class="font15">clinical </span>
   <span class="font15">treatment </span>
   <span class="font15">cells </span>
   <span class="font14">study </span>
   <span class="font14">using </span>
   <span class="font13">Neurology, </span>
   <span class="font13">compared </span>
   <span class="font13">brain </span>
   <span class="font13">States, </span>
   <span class="font13">lesions </span>
   <span class="font13">MS. </span>
   <span class="font13">cell </span>
   <span class="font13">significant </span>
   <span class="font12">significantly </span>
   <span class="font12">MRI </span>
   <span class="font12">mean </span>
   <span class="font12">Department </span>
   <span class="font12">data </span>
   <span class="font12">patients. </span>
   <span class="font12">associated </span>
   <span class="font12">EDSS </span>
   <span class="font12">Multiple </span>
   <span class="font12">analysis </span>
   <span class="font12">used </span>
   <span class="font12">increased </span>
   <span class="font12">Medical </span>
   <span class="font12">treated </span>
   <span class="font12">healthy </span>
   <span class="font12">age </span>
   <span class="font12">disability </span>
   <span class="font12">.). </span>
   <span class="font12">higher </span>
   <span class="font12">University, </span>
   <span class="font12">expression </span>
   <span class="font12">showed </span>
   <span class="font12">time </span>
   <span class="font12">RRMS </span>
   <span class="font12">Hospital, </span>
   <span class="font12">lesion </span>
   <span class="font12">months </span>
   <span class="font12">studies </span>
   <span class="font12">effect </span>
   <span class="font12">results </span>
   <span class="font12">years </span>
   <span class="font12">NMO </span>
   <span class="font12">levels </span>
   <span class="font11">(MS) </span>
   <span class="font11">effects </span>
   <span class="font11">baseline </span>
   <span class="font11">States </span>
   <span class="font11">Sclerosis </span>
   <span class="font11">risk </span>
   <span class="font11">performed </span>
   <span class="font11">fatigue </span>
   <span class="font11">optic </span>
   <span class="font11">Medicine, </span>
   <span class="font11">p&amp;lt; </span>
   <span class="font11">Center, </span>
   <span class="font11">group </span>
   <span class="font11">activity </span>
   <span class="font11">matter </span>
   <span class="font11">changes </span>
   <span class="font11">immune </span>
   <span class="font11">number </span>
   <span class="font11">patients, </span>
   <span class="font11">patient </span>
   <span class="font11">Italy, </span>
   <span class="font11">different </span>
   <span class="font11">score </span>
   <span class="font11">subjects </span>
   <span class="font11">Hospital </span>
   <span class="font11">relapse </span>
   <span class="font11">reported </span>
   <span class="font11">progressive </span>
   <span class="font11">controls </span>
   <span class="font11">MS, </span>
   <span class="font11">assessed </span>
   <span class="font11">differences </span>
   <span class="font11">model </span>
   <span class="font11">decreased </span>
   <span class="font11">duration </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">including </span>
   <span class="font11">visual </span>
   <span class="font11">relapsing-remitting </span>
   <span class="font11">Center </span>
   <span class="font11">quality </span>
   <span class="font11">measured </span>
   <span class="font11">role </span>
   <span class="font11">high </span>
   <span class="font11">increase </span>
   <span class="font11">observed </span>
   <span class="font11">year </span>
   <span class="font11">blood </span>
   <span class="font11">lower </span>
   <span class="font11">related </span>
   <span class="font11">included </span>
   <span class="font11">volume </span>
   <span class="font11">autoimmune </span>
   <span class="font11">atrophy </span>
   <span class="font11">control </span>
   <span class="font11">determine </span>
   <span class="font11">white </span>
   <span class="font11">function </span>
   <span class="font11">correlation </span>
   <span class="font11">imaging </span>
   <span class="font11">inflammatory </span>
   <span class="font11">human </span>
   <span class="font11">total </span>
   <span class="font11">.), </span>
   <span class="font11">cognitive </span>
   <span class="font11">School </span>
   <span class="font11">potential </span>
   <span class="font11">walking </span>
   <span class="font11">(p&amp;lt; </span>
   <span class="font11">did </span>
   <span class="font11">physical </span>
   <span class="font11">Clinical </span>
   <span class="font11">Research </span>
   <span class="font11">central </span>
   <span class="font11">diagnosis </span>
   <span class="font11">(%) </span>
   <span class="font11">cord </span>
   <span class="font11">(.%) </span>
   <span class="font11">change </span>
   <span class="font11">Institute </span>
   <span class="font11">New </span>
   <span class="font11">Scale </span>
   <span class="font11">new </span>
   <span class="font11">rate </span>
   <span class="font11">CNS </span>
   <span class="font11">functional </span>
   <span class="font11">therapy </span>
   <span class="font11">natalizumab </span>
   <span class="font11">scores </span>
   <span class="font11">Germany, </span>
   <span class="font11">Patients </span>
   <span class="font11">progression </span>
   <span class="font11">reduced </span>
   <span class="font11">use </span>
   <span class="font11">common </span>
   <span class="font11">impact </span>
   <span class="font11">mice </span>
   <span class="font11">spinal </span>
   <span class="font11">treatment. </span>
   <span class="font11">Canada, </span>
   <span class="font11">However, </span>
   <span class="font11">San </span>
   <span class="font11">cells. </span>
   <span class="font11">relationship </span>
   <span class="font11">evaluate </span>
   <span class="font11">findings </span>
   <span class="font11">life </span>
   <span class="font11">response </span>
   <span class="font11">serum </span>
   <span class="font11">Kingdom, </span>
   <span class="font11">follow-up </span>
   <span class="font11">identified </span>
   <span class="font11">measures </span>
   <span class="font11">symptoms </span>
   <span class="font11">MA, </span>
   <span class="font11">myelin </span>
   <span class="font11">test </span>
   <span class="font10">NY, </span>
   <span class="font10">cortical </span>
   <span class="font10">frequency </span>
   <span class="font10">median </span>
   <span class="font10">EAE </span>
   <span class="font10">important </span>
   <span class="font10">IL- </span>
   <span class="font10">positive </span>
   <span class="font10">based </span>
   <span class="font10">correlated </span>
   <span class="font10">factors </span>
   <span class="font10">groups </span>
   <span class="font10">normal </span>
   <span class="font10">specific </span>
   <span class="font10">suggest </span>
   <span class="font10">onset </span>
   <span class="font10">presence </span>
   <span class="font10">(MS). </span>
   <span class="font10">assess </span>
   <span class="font10">induced </span>
   <span class="font10">shown </span>
   <span class="font10">damage </span>
   <span class="font10">loss </span>
   <span class="font10">tissue </span>
   <span class="font10">differentiation </span>
   <span class="font10">optica </span>
   <span class="font10">relapsing </span>
   <span class="font10">severity </span>
   <span class="font10">clinically </span>
   <span class="font10">depression </span>
   <span class="font10">vs. </span>
   <span class="font10">peripheral </span>
   <span class="font10">antibody </span>
   <span class="font10">axonal </span>
   <span class="font10">nerve </span>
   <span class="font10">pregnancy </span>
   <span class="font10">difference </span>
   <span class="font10">identify </span>
   <span class="font10">isolated </span>
   <span class="font10">phase </span>
   <span class="font10">primary </span>
   <span class="font10">women </span>
   <span class="font10">acute </span>
   <span class="font10">controls. </span>
   <span class="font10">factor </span>
   <span class="font10">following </span>
   <span class="font10">status </span>
   <span class="font10">demonstrated </span>
   <span class="font10">development </span>
   <span class="font10">eyes </span>
   <span class="font10">present </span>
   <span class="font10">relapses </span>
   <span class="font10">antibodies </span>
   <span class="font10">protein </span>
   <span class="font10">demyelination </span>
   <span class="font10">evaluated </span>
   <span class="font10">evidence </span>
   <span class="font10">investigate </span>
   <span class="font10">low </span>
   <span class="font10">nervous </span>
   <span class="font10">severe </span>
   <span class="font10">trial </span>
   <span class="font10">(mean </span>
   <span class="font10">analyzed </span>
   <span class="font10">association </span>
   <span class="font10">early </span>
   <span class="font10">improvement </span>
   <span class="font10">neuritis </span>
   <span class="font10">obtained </span>
   <span class="font10">cohort </span>
   <span class="font10">demyelinating </span>
   <span class="font10">impairment </span>
   <span class="font10">motor </span>
   <span class="font10">outcomes </span>
   <span class="font10">p=.). </span>
   <span class="font10">study. </span>
   <span class="font10">gait </span>
   <span class="font10">measure </span>
   <span class="font10">received </span>
   <span class="font10">affected </span>
   <span class="font10">images </span>
   <span class="font10">scale </span>
   <span class="font10">CSF </span>
   <span class="font10">dysfunction </span>
   <span class="font10">outcome </span>
   <span class="font10">retinal </span>
   <span class="font10">therapeutic </span>
   <span class="font10">Institute, </span>
   <span class="font10">active </span>
   <span class="font10">fingolimod </span>
   <span class="font10">known </span>
   <span class="font10">parameters </span>
   <span class="font10">previously </span>
   <span class="font10">samples </span>
   <span class="font10">thickness </span>
   <span class="font10">Mean </span>
   <span class="font10">Medicine </span>
   <span class="font10">astrocytes </span>
   <span class="font10">genes </span>
   <span class="font10">p=.) </span>
   <span class="font10">age, </span>
   <span class="font10">course </span>
   <span class="font10">followed </span>
   <span class="font10">dose </span>
   <span class="font10">similar </span>
   <span class="font10">vivo </span>
   <span class="font10">Neurological </span>
   <span class="font10">York, </span>
   <span class="font10">better </span>
   <span class="font10">cases </span>
   <span class="font10">revealed </span>
   <span class="font10">NTZ </span>
   <span class="font10">PML </span>
   <span class="font10">RNFL </span>
   <span class="font10">children </span>
   <span class="font10">neuromyelitis </span>
   <span class="font10">range </span>
   <span class="font10">sexual </span>
   <span class="font10">values </span>
   <span class="font10">aim </span>
   <span class="font10">criteria </span>
   <span class="font10">days </span>
   <span class="font10">level </span>
   <span class="font10">oligodendrocyte </span>
   <span class="font10">participants </span>
   <span class="font10">people </span>
   <span class="font10">period </span>
   <span class="font10">proportion </span>
   <span class="font10">provide </span>
   <span class="font10">receptor </span>
   <span class="font10">regulatory </span>
   <span class="font10">Disability </span>
   <span class="font10">developed </span>
   <span class="font10">fampridine </span>
   <span class="font10">health </span>
   <span class="font10">lesions. </span>
   <span class="font10">previous </span>
   <span class="font10">single </span>
   <span class="font10">according </span>
   <span class="font10">expressed </span>
   <span class="font10">investigated </span>
   <span class="font10">months. </span>
   <span class="font10">neuronal </span>
   <span class="font10">prior </span>
   <span class="font10">years, </span>
   <span class="font10">Health </span>
   <span class="font10">Italy </span>
   <span class="font10">National </span>
   <span class="font10">efficacy </span>
   <span class="font10">greater </span>
   <span class="font10">pain </span>
   <span class="font10">population </span>
   <span class="font10">presented </span>
   <span class="font10">regression </span>
   <span class="font10">secondary </span>
   <span class="font10">.±. </span>
   <span class="font10">detected </span>
   <span class="font10">features </span>
   <span class="font10">sample </span>
   <span class="font10">underwent </span>
   <span class="font10">vitamin </span>
   <span class="font10">years. </span>
   <span class="font10">cells, </span>
   <span class="font10">month </span>
   <span class="font10">weeks </span>
   <span class="font10">(n=) </span>
   <span class="font10">CIS </span>
   <span class="font10">Neurology </span>
   <span class="font10">collected </span>
   <span class="font10">pediatric </span>
   <span class="font10">reduction </span>
   <span class="font10">responses </span>
   <span class="font10">safety </span>
   <span class="font10">vitro </span>
   <span class="font10">(p=.). </span>
   <span class="font10">FTY </span>
   <span class="font10">Fatigue </span>
   <span class="font10">Republic </span>
   <span class="font10">Sciences, </span>
   <span class="font10">activation </span>
   <span class="font10">adverse </span>
   <span class="font10">average </span>
   <span class="font10">characteristics </span>
   <span class="font10">chronic </span>
   <span class="font10">longitudinal </span>
   <span class="font10">syndrome </span>
   <span class="font10">trials </span>
   <span class="font10">diseases </span>
   <span class="font10">experimental </span>
   <span class="font10">index </span>
   <span class="font10">neurological </span>
   <span class="font10">pathology </span>
   <span class="font10">remyelination </span>
   <span class="font10">social </span>
   <span class="font10">spasticity </span>
   <span class="font10">Pediatric </span>
   <span class="font10">Spain, </span>
   <span class="font10">completed </span>
   <span class="font10">connectivity </span>
   <span class="font10">enrolled </span>
   <span class="font10">individual </span>
   <span class="font10">information </span>
   <span class="font10">involved </span>
   <span class="font10">lesions, </span>
   <span class="font10">markers </span>
   <span class="font10">respectively. </span>
   <span class="font10">stable </span>
   <span class="font10">London, </span>
   <span class="font10">Status </span>
   <span class="font10">decrease </span>
   <span class="font10">determined </span>
   <span class="font10">indicate </span>
   <span class="font10">involvement </span>
   <span class="font10">support </span>
   <span class="font10">BC, </span>
   <span class="font10">Vancouver, </span>
   <span class="font10">compare </span>
   <span class="font10">magnetic </span>
   <span class="font10">memory </span>
   <span class="font10">point </span>
   <span class="font10">rates </span>
   <span class="font10">standard </span>
   <span class="font10">study, </span>
   <span class="font10">type </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">CA, </span>
   <span class="font10">France, </span>
   <span class="font10">Germany </span>
   <span class="font10">JCV </span>
   <span class="font10">OCT </span>
   <span class="font10">considered </span>
   <span class="font10">improved </span>
   <span class="font10">injury </span>
   <span class="font10">negative </span>
   <span class="font10">possible </span>
   <span class="font10">regions </span>
   <span class="font10">versus </span>
   <span class="font10">(p=.) </span>
   <span class="font10">Brain </span>
   <span class="font10">MRS </span>
   <span class="font10">Unit, </span>
   <span class="font10">assessment </span>
   <span class="font10">cervical </span>
   <span class="font10">contribute </span>
   <span class="font10">current </span>
   <span class="font10">defined </span>
   <span class="font10">examined </span>
   <span class="font10">female </span>
   <span class="font10">influence </span>
   <span class="font10">matched </span>
   <span class="font10">novel </span>
   <span class="font10">Data </span>
   <span class="font10">Health, </span>
   <span class="font10">OH, </span>
   <span class="font10">encephalomyelitis </span>
   <span class="font10">independent </span>
   <span class="font10">layer </span>
   <span class="font10">remitting </span>
   <span class="font10">untreated </span>
   <span class="font10">SPMS </span>
   <span class="font10">acquired </span>
   <span class="font10">history </span>
   <span class="font10">overall </span>
   <span class="font10">production </span>
   <span class="font10">relative </span>
   <span class="font10">second </span>
   <span class="font10">state </span>
   <span class="font10">stem </span>
   <span class="font10">Cambridge, </span>
   <span class="font10">Expanded </span>
   <span class="font10">Fingolimod </span>
   <span class="font10">affect </span>
   <span class="font10">capacity </span>
   <span class="font10">density </span>
   <span class="font10">gene </span>
   <span class="font10">highly </span>
   <span class="font10">improve </span>
   <span class="font10">individuals </span>
   <span class="font10">remained </span>
   <span class="font10">report </span>
   <span class="font10">research </span>
   <span class="font10">suggests </span>
   <span class="font10">Boston, </span>
   <span class="font10">British </span>
   <span class="font10">Columbia, </span>
   <span class="font10">area </span>
   <span class="font10">case </span>
   <span class="font10">comparison </span>
   <span class="font10">derived </span>
   <span class="font10">evaluation </span>
   <span class="font10">left </span>
   <span class="font10">mechanisms </span>
   <span class="font10">performance </span>
   <span class="font10">population. </span>
   <span class="font10">resonance </span>
   <span class="font10">signaling </span>
   <span class="font10">Experimental </span>
   <span class="font10">aimed </span>
   <span class="font10">analyses </span>
   <span class="font10">baseline, </span>
   <span class="font10">experience </span>
   <span class="font10">seen </span>
   <span class="font10">treatment, </span>
   <span class="font10">(.% </span>
   <span class="font10">Australia, </span>
   <span class="font10">Using </span>
   <span class="font10">confirmed </span>
   <span class="font10">diagnosed </span>
   <span class="font10">grey </span>
   <span class="font10">inflammation </span>
   <span class="font10">long-term </span>
   <span class="font10">objective </span>
   <span class="font10">oligodendrocytes </span>
   <span class="font10">oral </span>
   <span class="font10">suggesting </span>
   <span class="font10">Centre </span>
   <span class="font10">IgG </span>
   <span class="font10">Korea, </span>
   <span class="font10">Milan, </span>
   <span class="font10">Neuromyelitis </span>
   <span class="font10">Raffaele </span>
   <span class="font10">State </span>
   <span class="font10">demyelination. </span>
   <span class="font10">disorders </span>
   <span class="font10">drug </span>
   <span class="font10">events </span>
   <span class="font10">follow </span>
   <span class="font10">global </span>
   <span class="font10">major </span>
   <span class="font10">training </span>
   <span class="font10">treatments </span>
   <span class="font10">Barcelona, </span>
   <span class="font10">College </span>
   <span class="font10">ON, </span>
   <span class="font10">School, </span>
   <span class="font10">alemtuzumab </span>
   <span class="font10">areas </span>
   <span class="font10">body </span>
   <span class="font10">characterized </span>
   <span class="font10">conducted </span>
   <span class="font10">correlations </span>
   <span class="font10">cytokine </span>
   <span class="font10">disease. </span>
   <span class="font10">effective </span>
   <span class="font10">examine </span>
   <span class="font10">iron </span>
   <span class="font10">marker </span>
   <span class="font10">network </span>
   <span class="font10">placebo </span>
   <span class="font10">recovery </span>
   <span class="font10">recruited </span>
   <span class="font10">tests </span>
   <span class="font10">therapy. </span>
   <span class="font10">(NMO) </span>
   <span class="font10">Kingdom </span>
   <span class="font10">NMO. </span>
   <span class="font10">available </span>
   <span class="font10">calculated </span>
   <span class="font10">develop </span>
   <span class="font10">disability. </span>
   <span class="font10">exposure </span>
   <span class="font10">flow </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">interferon </span>
   <span class="font10">items </span>
   <span class="font10">models </span>
   <span class="font10">of, </span>
   <span class="font10">pathological </span>
   <span class="font10">recent </span>
   <span class="font10">sleep </span>
   <span class="font10">speed </span>
   <span class="font10">subsets </span>
   <span class="font10">useful </span>
   <span class="font10">(%), </span>
   <span class="font10">.%, </span>
   <span class="font10">Biogen </span>
   <span class="font10">Centre, </span>
   <span class="font10">Cleveland, </span>
   <span class="font10">Turkey, </span>
   <span class="font10">abnormalities </span>
   <span class="font10">cerebral </span>
   <span class="font10">demonstrate </span>
   <span class="font10">group. </span>
   <span class="font10">impaired </span>
   <span class="font10">key </span>
   <span class="font10">molecular </span>
   <span class="font10">questionnaire </span>
   <span class="font10">right </span>
   <span class="font10">symptom </span>
   <span class="font10">therapies </span>
   <span class="font10">virus </span>
   <span class="font10">Liverpool, </span>
   <span class="font10">Treg </span>
   <span class="font10">contrast </span>
   <span class="font10">cortex </span>
   <span class="font10">groups. </span>
   <span class="font10">large </span>
   <span class="font10">macular </span>
   <span class="font10">main </span>
   <span class="font10">mediated </span>
   <span class="font10">moderate </span>
   <span class="font10">neural </span>
   <span class="font10">particularly </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">patients’ </span>
   <span class="font10">predictors </span>
   <span class="font10">pregnancies </span>
   <span class="font10">quantitative </span>
   <span class="font10">result </span>
   <span class="font10">scans </span>
   <span class="font10">statistically </span>
   <span class="font10">target </span>
   <span class="font10">week </span>
   <span class="font10">(RRMS) </span>
   <span class="font10">Clinic, </span>
   <span class="font10">EDSS, </span>
   <span class="font10">QC, </span>
   <span class="font10">Switzerland, </span>
   <span class="font10">ability </span>
   <span class="font10">addition, </span>
   <span class="font10">analysis. </span>
   <span class="font10">consistent </span>
   <span class="font10">degree </span>
   <span class="font10">detect </span>
   <span class="font10">fatigue, </span>
   <span class="font10">focal </span>
   <span class="font10">general </span>
   <span class="font10">having </span>
   <span class="font10">however, </span>
   <span class="font10">incidence </span>
   <span class="font10">include </span>
   <span class="font10">medical </span>
   <span class="font10">percentage </span>
   <span class="font10">prevalence </span>
   <span class="font10">tested </span>
   <span class="font10">tremor </span>
   <span class="font10">variables </span>
   <span class="font10">DMT </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">IL-, </span>
   <span class="font10">Neuroscience, </span>
   <span class="font10">Tregs </span>
   <span class="font10">activated </span>
   <span class="font10">animal </span>
   <span class="font10">approach </span>
   <span class="font10">brainstem </span>
   <span class="font10">daily </span>
   <span class="font10">does </span>
   <span class="font10">endothelial </span>
   <span class="font10">functions </span>
   <span class="font10">gut </span>
   <span class="font10">media </span>
   <span class="font10">required </span>
   <span class="font10">spectrum </span>
   <span class="font10">(EDSS) </span>
   <span class="font10">(MS), </span>
   <span class="font10">Berlin, </span>
   <span class="font10">MTR </span>
   <span class="font10">Montreal, </span>
   <span class="font10">NMOSD </span>
   <span class="font10">The </span>
   <span class="font10">balance </span>
   <span class="font10">correlate </span>
   <span class="font10">cuprizone </span>
   <span class="font10">cytokines </span>
   <span class="font10">established </span>
   <span class="font10">evoked </span>
   <span class="font10">gender, </span>
   <span class="font10">given </span>
   <span class="font10">likely </span>
   <span class="font10">mainly </span>
   <span class="font10">p=.), </span>
   <span class="font10">processes </span>
   <span class="font10">strong </span>
   <span class="font10">tomography </span>
   <span class="font10">walk </span>
   <span class="font10">(n=), </span>
   <span class="font10">(range </span>
   <span class="font10">BBB </span>
   <span class="font10">Cagliari, </span>
   <span class="font10">Canada </span>
   <span class="font10">Natalizumab </span>
   <span class="font10">Spain </span>
   <span class="font10">estimated </span>
   <span class="font10">glatiramer </span>
   <span class="font10">group, </span>
   <span class="font10">lack </span>
   <span class="font10">management </span>
   <span class="font10">occurred </span>
   <span class="font10">pattern </span>
   <span class="font10">poor </span>
   <span class="font10">promote </span>
   <span class="font10">provides </span>
   <span class="font10">regarding </span>
   <span class="font10">repair </span>
   <span class="font10">stress </span>
   <span class="font10">testing </span>
   <span class="font10">tool </span>
   <span class="font10">years) </span>
   <span class="font10">DAC </span>
   <span class="font10">Department, </span>
   <span class="font10">NAT </span>
   <span class="font10">P&amp;lt; </span>
   <span class="font10">Treatment </span>
   <span class="font10">acetate </span>
   <span class="font10">addition </span>
   <span class="font10">additional </span>
   <span class="font10">anxiety </span>
   <span class="font10">approved </span>
   <span class="font10">axons </span>
   <span class="font10">coherence </span>
   <span class="font10">confirm </span>
   <span class="font10">elevated </span>
   <span class="font10">experienced </span>
   <span class="font10">fit </span>
   <span class="font10">frequently </span>
   <span class="font10">immunological </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">mechanism </span>
   <span class="font10">mice. </span>
   <span class="font10">order </span>
   <span class="font10">pathway </span>
   <span class="font10">patterns </span>
   <span class="font10">prospective </span>
   <span class="font10">proteins </span>
   <span class="font10">recently </span>
   <span class="font10">relevant </span>
   <span class="font10">sclerosis: </span>
   <span class="font10">stimulation </span>
   <span class="font10">studied </span>
   <span class="font10">suggested </span>
   <span class="font10">surface </span>
   <span class="font10">transfer </span>
   <span class="font10">(.) </span>
   <span class="font10">(.±. </span>
   <span class="font10">(SD) </span>
   <span class="font10">Depression </span>
   <span class="font10">Faculty </span>
   <span class="font10">Group </span>
   <span class="font10">and/or </span>
   <span class="font10">bladder </span>
   <span class="font10">classified </span>
   <span class="font10">commonly </span>
   <span class="font10">complex </span>
   <span class="font10">day </span>
   <span class="font10">described </span>
   <span class="font10">fluid </span>
   <span class="font10">frequent </span>
   <span class="font10">induce </span>
   <span class="font10">initial </span>
   <span class="font10">item </span>
   <span class="font10">mental </span>
   <span class="font10">modifying </span>
   <span class="font10">need </span>
   <span class="font10">needed </span>
   <span class="font10">predictive </span>
   <span class="font10">program </span>
   <span class="font10">randomized </span>
   <span class="font10">ratio </span>
   <span class="font10">regulation </span>
   <span class="font10">sensitive </span>
   <span class="font10">sequences </span>
   <span class="font10">small </span>
   <span class="font10">subset </span>
   <span class="font10">targets </span>
   <span class="font10">validated </span>
   <span class="font10">volumes </span>
   <span class="font10">work </span>
   <span class="font10">years; </span>
   <span class="font10">DNA </span>
   <span class="font10">ON. </span>
   <span class="font10">Phase </span>
   <span class="font10">Radiology, </span>
   <span class="font10">Rasch </span>
   <span class="font10">Research, </span>
   <span class="font10">Study </span>
   <span class="font10">T-cell </span>
   <span class="font10">Trust, </span>
   <span class="font10">Women’s </span>
   <span class="font10">accumulation </span>
   <span class="font10">analysis, </span>
   <span class="font10">applied </span>
   <span class="font10">attack </span>
   <span class="font10">circulating </span>
   <span class="font10">data. </span>
   <span class="font10">distribution </span>
   <span class="font10">exercise </span>
   <span class="font10">explore </span>
   <span class="font10">follow-up. </span>
   <span class="font10">gray </span>
   <span class="font10">indicated </span>
   <span class="font10">persons </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">proliferation </span>
   <span class="font10">recorded </span>
   <span class="font10">sclerosis. </span>
   <span class="font10">statistical </span>
   <span class="font10">understanding </span>
   <span class="font10">Cleveland </span>
   <span class="font10">Francisco, </span>
   <span class="font10">HRQoL </span>
   <span class="font10">Idec, </span>
   <span class="font10">Inc., </span>
   <span class="font10">MOG </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Physical </span>
   <span class="font10">alterations </span>
   <span class="font10">altered </span>
   <span class="font10">antigen </span>
   <span class="font10">bilateral </span>
   <span class="font10">care </span>
   <span class="font10">caused </span>
   <span class="font10">complete </span>
   <span class="font10">demographic </span>
   <span class="font10">domains </span>
   <span class="font10">gender </span>
   <span class="font10">importance </span>
   <span class="font10">infusion </span>
   <span class="font10">interaction </span>
   <span class="font10">larger </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">male </span>
   <span class="font10">monitoring </span>
   <span class="font10">process </span>
   <span class="font10">radiological </span>
   <span class="font10">routine </span>
   <span class="font10">terms </span>
   <span class="font10">worsening </span>
   <span class="font10">(,%) </span>
   <span class="font10">(n=). </span>
   <span class="font10">Göttingen, </span>
   <span class="font10">IFN-beta </span>
   <span class="font10">MSC </span>
   <span class="font10">NAWM </span>
   <span class="font10">Neurosciences, </span>
   <span class="font10">Scientific </span>
   <span class="font10">abnormal </span>
   <span class="font10">absence </span>
   <span class="font10">bone </span>
   <span class="font10">episode </span>
   <span class="font10">fiber </span>
   <span class="font10">free </span>
   <span class="font10">good </span>
   <span class="font10">life. </span>
   <span class="font10">longer </span>
   <span class="font10">method </span>
   <span class="font10">microglia </span>
   <span class="font10">migration </span>
   <span class="font10">mild </span>
   <span class="font10">modified </span>
   <span class="font10">multifocal </span>
   <span class="font10">neuropsychological </span>
   <span class="font10">pathways </span>
   <span class="font10">phenotype </span>
   <span class="font10">predict </span>
   <span class="font10">predicted </span>
   <span class="font10">retrospective </span>
   <span class="font10">satisfaction </span>
   <span class="font10">sites </span>
   <span class="font10">studies, </span>
   <span class="font10">system. </span>
   <span class="font10">task </span>
   <span class="font10">temperature </span>
   <span class="font10">underlying </span>
   <span class="font10">value </span>
   <span class="font10">(&amp;lt; </span>
   <span class="font10">Buffalo, </span>
   <span class="font10">City, </span>
   <span class="font10">Compared </span>
   <span class="font10">GCL </span>
   <span class="font10">Genoa, </span>
   <span class="font10">MD, </span>
   <span class="font10">MSCs </span>
   <span class="font10">NMO, </span>
   <span class="font10">OPCs </span>
   <span class="font10">Optic </span>
   <span class="font10">Prague, </span>
   <span class="font10">RLS </span>
   <span class="font10">VEP </span>
   <span class="font10">analysed </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">barrier </span>
   <span class="font10">biomarker </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">differ </span>
   <span class="font10">donors </span>
   <span class="font10">duration, </span>
   <span class="font10">enhanced </span>
   <span class="font10">expected </span>
   <span class="font10">extensive </span>
   <span class="font10">extent </span>
   <span class="font10">generated </span>
   <span class="font10">glial </span>
   <span class="font10">increasing </span>
   <span class="font10">lead </span>
   <span class="font10">long </span>
   <span class="font10">mRNA </span>
   <span class="font10">microbiome </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mouse </span>
   <span class="font10">muscle </span>
   <span class="font10">naïve </span>
   <span class="font10">neurodegenerative </span>
   <span class="font10">numbers </span>
   <span class="font10">ongoing </span>
   <span class="font10">perceived </span>
   <span class="font10">potentials </span>
   <span class="font10">preliminary </span>
   <span class="font10">profile </span>
   <span class="font10">progression. </span>
   <span class="font10">protective </span>
   <span class="font10">provided </span>
   <span class="font10">recurrent </span>
   <span class="font10">reduce </span>
   <span class="font10">relationships </span>
   <span class="font10">resulted </span>
   <span class="font10">resulting </span>
   <span class="font10">signal </span>
   <span class="font10">specifically </span>
   <span class="font10">studies. </span>
   <span class="font10">sustained </span>
   <span class="font10">upper </span>
   <span class="font10">variability </span>
   <span class="font10">.%; </span>
   <span class="font10">ADEM </span>
   <span class="font10">Amsterdam, </span>
   <span class="font10">B-cells </span>
   <span class="font10">Brigham </span>
   <span class="font10">Children’s </span>
   <span class="font10">DMF </span>
   <span class="font10">General </span>
   <span class="font10">High </span>
   <span class="font10">Kim </span>
   <span class="font10">Laboratory </span>
   <span class="font10">MSWS- </span>
   <span class="font10">Magnetic </span>
   <span class="font10">McDonald </span>
   <span class="font10">McGill </span>
   <span class="font10">NHS </span>
   <span class="font10">TNFα </span>
   <span class="font10">affecting </span>
   <span class="font10">appearing </span>
   <span class="font10">appears </span>
   <span class="font10">biomarkers </span>
   <span class="font10">cause </span>
   <span class="font10">component </span>
   <span class="font10">critical </span>
   <span class="font10">dependent </span>
   <span class="font10">deposition </span>
   <span class="font10">direct </span>
   <span class="font10">diseases. </span>
   <span class="font10">effector </span>
   <span class="font10">functioning </span>
   <span class="font10">model. </span>
   <span class="font10">points </span>
   <span class="font10">reliable </span>
   <span class="font10">remains </span>
   <span class="font10">responders </span>
   <span class="font10">resting </span>
   <span class="font10">selected </span>
   <span class="font10">sensitivity </span>
   <span class="font10">stability </span>
   <span class="font10">strongly </span>
   <span class="font10">subsequent </span>
   <span class="font10">susceptibility </span>
   <span class="font10">thinning </span>
   <span class="font10">types </span>
   <span class="font10">Analysis </span>
   <span class="font10">Biomedical </span>
   <span class="font10">Calgary, </span>
   <span class="font10">Clinic </span>
   <span class="font10">Dept. </span>
   <span class="font10">France </span>
   <span class="font10">IVIG </span>
   <span class="font10">Imaging </span>
   <span class="font10">Impact </span>
   <span class="font10">Melbourne, </span>
   <span class="font10">PPMS </span>
   <span class="font10">St. </span>
   <span class="font10">activity. </span>
   <span class="font10">aged </span>
   <span class="font10">aspects </span>
   <span class="font10">assessing </span>
   <span class="font10">binding </span>
   <span class="font10">concentrations </span>
   <span class="font10">corpus </span>
   <span class="font10">correlates </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">detection </span>
   <span class="font10">diagnostic </span>
   <span class="font10">differential </span>
   <span class="font10">event </span>
   <span class="font10">finding </span>
   <span class="font10">future </span>
   <span class="font10">glutamate </span>
   <span class="font10">help </span>
   <span class="font10">implicated </span>
   <span class="font10">inhibition </span>
   <span class="font10">injection </span>
   <span class="font10">leukoencephalopathy </span>
   <span class="font10">like </span>
   <span class="font10">monocytes </span>
   <span class="font10">normalized </span>
   <span class="font10">occur </span>
   <span class="font10">patient’s </span>
   <span class="font10">potentially </span>
   <span class="font10">regional </span>
   <span class="font10">relapses. </span>
   <span class="font10">relation </span>
   <span class="font10">response. </span>
   <span class="font10">sequence </span>
   <span class="font10">stages </span>
   <span class="font10">utility </span>
   <span class="font10">{border-style </span>
   <span class="font10">(ON) </span>
   <span class="font10">-year </span>
   <span class="font10">Bochum, </span>
   <span class="font10">Despite </span>
   <span class="font10">Disease </span>
   <span class="font10">EAE. </span>
   <span class="font10">Foundation </span>
   <span class="font10">Functional </span>
   <span class="font10">IFN </span>
   <span class="font10">Italian </span>
   <span class="font10">London </span>
   <span class="font10">MAIT </span>
   <span class="font10">Molecular </span>
   <span class="font10">Netherlands, </span>
   <span class="font10">Network </span>
   <span class="font10">QOL </span>
   <span class="font10">York </span>
   <span class="font10">action </span>
   <span class="font10">administered </span>
   <span class="font10">administration </span>
   <span class="font10">annualized </span>
   <span class="font10">anterior </span>
   <span class="font10">associations </span>
   <span class="font10">autoantibodies </span>
   <span class="font10">autologous </span>
   <span class="font10">cancer </span>
   <span class="font10">clinic </span>
   <span class="font10">combined </span>
   <span class="font10">comparing </span>
   <span class="font10">conditions </span>
   <span class="font10">controlled </span>
   <span class="font10">controls, </span>
   <span class="font10">conversion </span>
   <span class="font10">developing </span>
   <span class="font10">differentially </span>
   <span class="font10">disability, </span>
   <span class="font10">distinct </span>
   <span class="font10">double </span>
   <span class="font10">expansion </span>
   <span class="font10">fatigue. </span>
   <span class="font10">form </span>
   <span class="font10">groups, </span>
   <span class="font10">image </span>
   <span class="font10">improvements </span>
   <span class="font10">induction </span>
   <span class="font10">interval </span>
   <span class="font10">local </span>
   <span class="font10">marrow </span>
   <span class="font10">neurons </span>
   <span class="font10">occurs </span>
   <span class="font10">optical </span>
   <span class="font10">practice </span>
   <span class="font10">properties </span>
   <span class="font10">protection </span>
   <span class="font10">regulated </span>
   <span class="font10">relatively </span>
   <span class="font10">segmentation </span>
   <span class="font10">sex </span>
   <span class="font10">subjects. </span>
   <span class="font10">syndromes </span>
   <span class="font10">technique </span>
   <span class="font10">unknown. </span>
   <span class="font10">uptake </span>
   <span class="font10">worse </span>
   <span class="font10">−., </span>
   <span class="font10">(%). </span>
   <span class="font10">(EAE) </span>
   <span class="font10">(SD </span>
   <span class="font10">CARE-MS </span>
   <span class="font10">Central </span>
   <span class="font10">Division </span>
   <span class="font10">Finally, </span>
   <span class="font10">HIFC </span>
   <span class="font10">Immunology, </span>
   <span class="font10">Longitudinal </span>
   <span class="font10">MS: </span>
   <span class="font10">MWF </span>
   <span class="font10">NJ, </span>
   <span class="font10">PDDS </span>
   <span class="font10">Previous </span>
   <span class="font10">Progressive </span>
   <span class="font10">QoL </span>
   <span class="font10">RGC- </span>
   <span class="font10">Regional </span>
   <span class="font10">T-cells </span>
   <span class="font10">T-weighted </span>
   <span class="font10">UCCA </span>
   <span class="font10">able </span>
   <span class="font10">affects </span>
   <span class="font10">assay </span>
   <span class="font10">c-Myc </span>
   <span class="font10">center </span>
   <span class="font10">cohort. </span>
   <span class="font10">contrast, </span>
   <span class="font10">core </span>
   <span class="font10">definite </span>
   <span class="font10">demyelinated </span>
   <span class="font10">depression, </span>
   <span class="font10">disease-modifying </span>
   <span class="font10">divided </span>
   <span class="font10">drugs </span>
   <span class="font10">extracted </span>
   <span class="font10">feature </span>
   <span class="font10">females </span>
   <span class="font10">final </span>
   <span class="font10">induces </span>
   <span class="font10">intensity </span>
   <span class="font10">intervention </span>
   <span class="font10">intravenous </span>
   <span class="font10">knowledge </span>
   <span class="font10">later </span>
   <span class="font10">leading </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">metrics </span>
   <span class="font10">modulation </span>
   <span class="font10">mononuclear </span>
   <span class="font10">myelitis </span>
   <span class="font10">patient-reported </span>
   <span class="font10">presenting </span>
   <span class="font10">px;} </span>
   <span class="font10">quantify </span>
   <span class="font10">rat </span>
   <span class="font10">reactive </span>
   <span class="font10">receiving </span>
   <span class="font10">reducing </span>
   <span class="font10">relevance </span>
   <span class="font10">set </span>
   <span class="font10">spine </span>
   <span class="font10">spontaneous </span>
   <span class="font10">subject </span>
   <span class="font10">survival </span>
   <span class="font10">temporal </span>
   <span class="font10">trend </span>
   <span class="font10">trials. </span>
   <span class="font10">unique </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(MRI) </span>
   <span class="font10">,,, </span>
   <span class="font10">Based </span>
   <span class="font10">CD, </span>
   <span class="font10">CNS. </span>
   <span class="font10">Czech </span>
   <span class="font10">ELISA </span>
   <span class="font10">Harvard </span>
   <span class="font10">January </span>
   <span class="font10">NPCs </span>
   <span class="font10">PRO </span>
   <span class="font10">Philadelphia, </span>
   <span class="font10">Royal </span>
   <span class="font10">TFW </span>
   <span class="font10">Vall </span>
   <span class="font10">adjusting </span>
   <span class="font10">analyze </span>
   <span class="font10">attacks </span>
   <span class="font10">classification </span>
   <span class="font10">condition </span>
   <span class="font10">consecutive </span>
   <span class="font10">conventional </span>
   <span class="font10">count </span>
   <span class="font10">currently </span>
   <span class="font10">dendritic </span>
   <span class="font10">disease, </span>
   <span class="font10">disorder </span>
   <span class="font10">educational </span>
   <span class="font10">hippocampal </span>
   <span class="font10">illness </span>
   <span class="font10">increases </span>
   <span class="font10">infection </span>
   <span class="font10">largely </span>
   <span class="font10">led </span>
   <span class="font10">linked </span>
   <span class="font10">majority </span>
   <span class="font10">measurements </span>
   <span class="font10">measuring </span>
   <span class="font10">medication </span>
   <span class="font10">met </span>
   <span class="font10">months, </span>
   <span class="font10">neuroprotective </span>
   <span class="font10">play </span>
   <span class="font10">predictor </span>
   <span class="font10">presentation </span>
   <span class="font10">represent </span>
   <span class="font10">review </span>
   <span class="font10">shows </span>
   <span class="font10">stage </span>
   <span class="font10">status, </span>
   <span class="font10">step </span>
   <span class="font10">subjective </span>
   <span class="font10">survey </span>
   <span class="font10">symptoms, </span>
   <span class="font10">times </span>
   <span class="font10">toxin </span>
   <span class="font10">upregulated </span>
   <span class="font10">urinary </span>
   <span class="font10">venous </span>
   <span class="font10">(CNS) </span>
   <span class="font10">(OR </span>
   <span class="font10">(r=., </span>
   <span class="font10">-., </span>
   <span class="font10">ARR </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Case </span>
   <span class="font10">Cognitive </span>
   <span class="font10">DIR </span>
   <span class="font10">HYP </span>
   <span class="font10">Israel </span>
   <span class="font10">Japan, </span>
   <span class="font10">KIR. </span>
   <span class="font10">MS-related </span>
   <span class="font10">March </span>
   <span class="font10">NMO/NMOSD </span>
   <span class="font10">Patient </span>
   <span class="font10">RRMS. </span>
   <span class="font10">Stony </span>
   <span class="font10">Toronto, </span>
   <span class="font10">Vitamin </span>
   <span class="font10">WML </span>
   <span class="font10">Walking </span>
   <span class="font10">Wang </span>
   <span class="font10">adult </span>
   <span class="font10">allow </span>
   <span class="font10">animals </span>
   <span class="font10">anti-AQP </span>
   <span class="font10">best </span>
   <span class="font10">biological </span>
   <span class="font10">burden </span>
   <span class="font10">comparable </span>
   <span class="font10">comparisons </span>
   <span class="font10">complement </span>
   <span class="font10">decline </span>
   <span class="font10">degeneration </span>
   <span class="font10">design </span>
   <span class="font10">designed </span>
   <span class="font10">directly </span>
   <span class="font10">distinguish </span>
   <span class="font10">enhancing </span>
   <span class="font10">environmental </span>
   <span class="font10">expanded </span>
   <span class="font10">exposed </span>
   <span class="font10">express </span>
   <span class="font10">falls </span>
   <span class="font10">female, </span>
   <span class="font10">first-line </span>
   <span class="font10">forms </span>
   <span class="font10">frontal </span>
   <span class="font10">ganglion </span>
   <span class="font10">generation </span>
   <span class="font10">genetic </span>
   <span class="font10">half </span>
   <span class="font10">indicates </span>
   <span class="font10">indicating </span>
   <span class="font10">infections </span>
   <span class="font10">leads </span>
   <span class="font10">length </span>
   <span class="font10">line </span>
   <span class="font10">little </span>
   <span class="font10">measurement </span>
   <span class="font10">metabolic </span>
   <span class="font10">neurodegeneration </span>
   <span class="font10">neurophysiological </span>
   <span class="font10">neutralization </span>
   <span class="font10">observation </span>
   <span class="font10">oligoclonal </span>
   <span class="font10">onset, </span>
   <span class="font10">performed. </span>
   <span class="font10">permeability </span>
   <span class="font10">personality </span>
   <span class="font10">populations </span>
   <span class="font10">problems </span>
   <span class="font10">processing </span>
   <span class="font10">recognized </span>
   <span class="font10">reflect </span>
   <span class="font10">reporting </span>
   <span class="font10">robust </span>
   <span class="font10">scores. </span>
   <span class="font10">selective </span>
   <span class="font10">sensory </span>
   <span class="font10">series </span>
   <span class="font10">significance </span>
   <span class="font10">thoracic </span>
   <span class="font10">twice </span>
   <span class="font10">understand </span>
   <span class="font10">various </span>
   <span class="font10">weeks. </span>
   <span class="font10">%), </span>
   <span class="font10">(n=, </span>
   <span class="font10">-month </span>
   <span class="font10">.); </span>
   <span class="font10">AB, </span>
   <span class="font10">Balance </span>
   <span class="font10">Baseline </span>
   <span class="font10">FLAIR </span>
   <span class="font10">HC, </span>
   <span class="font10">Israel, </span>
   <span class="font10">Median </span>
   <span class="font10">Modena, </span>
   <span class="font10">NMO-IgG </span>
   <span class="font10">Ospedale </span>
   <span class="font10">PA, </span>
   <span class="font10">PBMCs </span>
   <span class="font10">PLEX </span>
   <span class="font10">PML. </span>
   <span class="font10">PSA </span>
   <span class="font10">Participants </span>
   <span class="font10">RMS </span>
   <span class="font10">Severity </span>
   <span class="font10">Tel </span>
   <span class="font10">adjusted </span>
   <span class="font10">adults </span>
   <span class="font10">ambulatory </span>
   <span class="font10">annual </span>
   <span class="font10">anti-JCV </span>
   <span class="font10">attention </span>
   <span class="font10">beneficial </span>
   <span class="font10">benefits </span>
   <span class="font10">beta </span>
   <span class="font10">bowel </span>
   <span class="font10">clinical, </span>
   <span class="font10">components </span>
   <span class="font10">concentration </span>
   <span class="font10">course. </span>
   <span class="font10">cytometry </span>
   <span class="font10">deep </span>
   <span class="font10">disabling </span>
   <span class="font10">domain </span>
   <span class="font10">estimates </span>
   <span class="font10">excluded </span>
   <span class="font10">exhibited </span>
   <span class="font10">experiments </span>
   <span class="font10">family </span>
   <span class="font10">findings. </span>
   <span class="font10">follow-up, </span>
   <span class="font10">frequencies </span>
   <span class="font10">glucose </span>
   <span class="font10">health-related </span>
   <span class="font10">hours </span>
   <span class="font10">identification </span>
   <span class="font10">influenced </span>
   <span class="font10">intracellular </span>
   <span class="font10">laboratory </span>
   <span class="font10">lateral </span>
   <span class="font10">limited </span>
   <span class="font10">lymph </span>
   <span class="font10">maintained </span>
   <span class="font10">means </span>
   <span class="font10">miR- </span>
   <span class="font10">multivariate </span>
   <span class="font10">negatively </span>
   <span class="font10">observational </span>
   <span class="font10">period. </span>
   <span class="font10">population, </span>
   <span class="font10">post </span>
   <span class="font10">power </span>
   <span class="font10">predominantly </span>
   <span class="font10">proinflammatory </span>
   <span class="font10">prospectively </span>
   <span class="font10">puberty </span>
   <span class="font10">quantified </span>
   <span class="font10">receptors </span>
   <span class="font10">remyelination. </span>
   <span class="font10">represents </span>
   <span class="font10">second-line </span>
   <span class="font10">setting </span>
   <span class="font10">sex, </span>
   <span class="font10">starting </span>
   <span class="font10">strategies </span>
   <span class="font10">structural </span>
   <span class="font10">superior </span>
   <span class="font10">system, </span>
   <span class="font10">term </span>
   <span class="font10">time, </span>
   <span class="font10">tract </span>
   <span class="font10">unaffected </span>
   <span class="font10">variable </span>
   <span class="font10">variance </span>
   <span class="font10">vascular </span>
   <span class="font10">vision </span>
   <span class="font10">water </span>
   <span class="font10">withdrawal </span>
   <span class="font10">%). </span>
   <span class="font10">(OCT) </span>
   <span class="font10">(PML) </span>
   <span class="font10">(WM) </span>
   <span class="font10">(p=.), </span>
   <span class="font10">-item </span>
   <span class="font10">.-.). </span>
   <span class="font10">AQP-IgG </span>
   <span class="font10">Basel, </span>
   <span class="font10">Birmingham, </span>
   <span class="font10">Caen, </span>
   <span class="font10">Cancer </span>
   <span class="font10">College, </span>
   <span class="font10">DMD </span>
   <span class="font10">DMTs </span>
   <span class="font10">FLAIR* </span>
   <span class="font10">Florence, </span>
   <span class="font10">GPR </span>
   <span class="font10">HSC </span>
   <span class="font10">Here, </span>
   <span class="font10">IL, </span>
   <span class="font10">Index </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">LAQ </span>
   <span class="font10">Leeds, </span>
   <span class="font10">Lhermitte’s </span>
   <span class="font10">MFIS </span>
   <span class="font10">MRI, </span>
   <span class="font10">Neuroimmunology </span>
   <span class="font10">Oxford, </span>
   <span class="font10">PBMC </span>
   <span class="font10">PR-fampridine </span>
   <span class="font10">Seoul, </span>
   <span class="font10">Test </span>
   <span class="font10">Torino, </span>
   <span class="font10">Turkey </span>
   <span class="font10">VEPs </span>
   <span class="font10">Visual </span>
   <span class="font10">Western </span>
   <span class="font10">acuity </span>
   <span class="font10">affinity </span>
   <span class="font10">basic </span>
   <span class="font10">benefit </span>
   <span class="font10">brain. </span>
   <span class="font10">breastfeeding </span>
   <span class="font10">cellular </span>
   <span class="font10">channel </span>
   <span class="font10">characterize </span>
   <span class="font10">combination </span>
   <span class="font10">diffusion </span>
   <span class="font10">discontinued </span>
   <span class="font10">dynamic </span>
   <span class="font10">epsilon </span>
   <span class="font10">estimate </span>
   <span class="font10">expression. </span>
   <span class="font10">extension </span>
   <span class="font10">fMRI </span>
   <span class="font10">generate </span>
   <span class="font10">growth </span>
   <span class="font10">iNKT </span>
   <span class="font10">images. </span>
   <span class="font10">improving </span>
   <span class="font10">included. </span>
   <span class="font10">inflammation. </span>
   <span class="font10">initiation </span>
   <span class="font10">interferon-beta </span>
   <span class="font10">linear </span>
   <span class="font10">load </span>
   <span class="font10">lymphoid </span>
   <span class="font10">maps </span>
   <span class="font10">metabolite </span>
   <span class="font10">methods </span>
   <span class="font10">miRNAs </span>
   <span class="font10">mobility </span>
   <span class="font10">model, </span>
   <span class="font10">modifications </span>
   <span class="font10">observed. </span>
   <span class="font10">p=.; </span>
   <span class="font10">pDCs </span>
   <span class="font10">pathogenic </span>
   <span class="font10">peak </span>
   <span class="font10">percent </span>
   <span class="font10">periventricular </span>
   <span class="font10">procedure </span>
   <span class="font10">prolonged </span>
   <span class="font10">prospective, </span>
   <span class="font10">protects </span>
   <span class="font10">published </span>
   <span class="font10">rare </span>
   <span class="font10">recruitment </span>
   <span class="font10">remission </span>
   <span class="font10">reported. </span>
   <span class="font10">residual </span>
   <span class="font10">resolution </span>
   <span class="font10">respectively </span>
   <span class="font10">respectively). </span>
   <span class="font10">reveal </span>
   <span class="font10">screening </span>
   <span class="font10">secretion </span>
   <span class="font10">sera </span>
   <span class="font10">seropositive </span>
   <span class="font10">short </span>
   <span class="font10">signalling </span>
   <span class="font10">software </span>
   <span class="font10">stained </span>
   <span class="font10">subjects, </span>
   <span class="font10">systemic </span>
   <span class="font10">teriflunomide </span>
   <span class="font10">test. </span>
   <span class="font10">testosterone </span>
   <span class="font10">threshold </span>
   <span class="font10">traits </span>
   <span class="font10">vehicle </span>
   <span class="font10">visit </span>
   <span class="font10">women, </span>
   <span class="font10">(-) </span>
   <span class="font10">(/) </span>
   <span class="font10">(EDSS </span>
   <span class="font10">(HC) </span>
   <span class="font10">-). </span>
   <span class="font10">.±., </span>
   <span class="font10">ADS </span>
   <span class="font10">ANOVA </span>
   <span class="font10">According </span>
   <span class="font10">Brook, </span>
   <span class="font10">California </span>
   <span class="font10">Charles </span>
   <span class="font10">Children, </span>
   <span class="font10">DCs </span>
   <span class="font10">DTI </span>
   <span class="font10">EBV </span>
   <span class="font10">Foundation, </span>
   <span class="font10">GSK </span>
   <span class="font10">Gait </span>
   <span class="font10">Hannover, </span>
   <span class="font10">Hospitals </span>
   <span class="font10">III </span>
   <span class="font10">IVMP </span>
   <span class="font10">John </span>
   <span class="font10">Life </span>
   <span class="font10">MRI. </span>
   <span class="font10">MSC-NPs </span>
   <span class="font10">Modified </span>
   <span class="font10">Month </span>
   <span class="font10">Munich, </span>
   <span class="font10">NEDA </span>
   <span class="font10">Neuroimaging </span>
   <span class="font10">PDPN </span>
   <span class="font10">Preliminary </span>
   <span class="font10">Psychiatry, </span>
   <span class="font10">Public </span>
   <span class="font10">Queen </span>
   <span class="font10">Questionnaire </span>
   <span class="font10">RNA </span>
   <span class="font10">Rehabilitation </span>
   <span class="font10">Results </span>
   <span class="font10">Science, </span>
   <span class="font10">Secondary </span>
   <span class="font10">Significant </span>
   <span class="font10">TLR </span>
   <span class="font10">Vita-Salute </span>
   <span class="font10">adherence </span>
   <span class="font10">aims </span>
   <span class="font10">allows </span>
   <span class="font10">anti </span>
   <span class="font10">appear </span>
   <span class="font10">application </span>
   <span class="font10">astrocyte </span>
   <span class="font10">beta-a </span>
   <span class="font10">blocks </span>
   <span class="font10">blood-brain </span>
   <span class="font10">brains </span>
   <span class="font10">bright </span>
   <span class="font10">calcitriol </span>
   <span class="font10">callosum </span>
   <span class="font10">cases, </span>
   <span class="font10">characterization </span>
   <span class="font10">conduction </span>
   <span class="font10">criteria. </span>
   <span class="font10">database </span>
   <span class="font10">decreases </span>
   <span class="font10">delayed-release </span>
   <span class="font10">differentiate </span>
   <span class="font10">differentiation. </span>
   <span class="font10">dimethyl </span>
   <span class="font10">directed </span>
   <span class="font10">disorders. </span>
   <span class="font10">doses </span>
   <span class="font10">dynamics </span>
   <span class="font10">endogenous </span>
   <span class="font10">especially </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">hypothesis </span>
   <span class="font10">immunohistochemistry </span>
   <span class="font10">impairment. </span>
   <span class="font10">impairments </span>
   <span class="font10">independently </span>
   <span class="font10">infratentorial </span>
   <span class="font10">integration </span>
   <span class="font10">intrathecal </span>
   <span class="font10">literature </span>
   <span class="font10">longitudinally </span>
   <span class="font10">loss, </span>
   <span class="font10">loss. </span>
   <span class="font10">manual </span>
   <span class="font10">molecule </span>
   <span class="font10">molecules </span>
   <span class="font10">natural </span>
   <span class="font10">occurring </span>
   <span class="font10">onset. </span>
   <span class="font10">oxidative </span>
   <span class="font10">oxygen </span>
   <span class="font10">past </span>
   <span class="font10">patients: </span>
   <span class="font10">peptide </span>
   <span class="font10">plasma </span>
   <span class="font10">postpartum </span>
   <span class="font10">profiles </span>
   <span class="font10">promotes </span>
   <span class="font10">proposed </span>
   <span class="font10">psychiatric </span>
   <span class="font10">purified </span>
   <span class="font10">reactivation </span>
   <span class="font10">rehabilitation </span>
   <span class="font10">release </span>
   <span class="font10">respect </span>
   <span class="font10">reviewed </span>
   <span class="font10">score. </span>
   <span class="font10">sign </span>
   <span class="font10">substantial </span>
   <span class="font10">sway </span>
   <span class="font10">taken </span>
   <span class="font10">transplantation </span>
   <span class="font10">van </span>
   <span class="font10">velocity </span>
   <span class="font10">voxels </span>
   <span class="font10">woman </span>
   <span class="font10">(.%), </span>
   <span class="font10">(RR) </span>
   <span class="font10">(RRMS). </span>
   <span class="font10">(all </span>
   <span class="font10">(n= </span>
   <span class="font10">(p=., </span>
   <span class="font10">-week </span>
   <span class="font10">ACTH </span>
   <span class="font10">April </span>
   <span class="font10">Beck </span>
   <span class="font10">CHU </span>
   <span class="font10">CO, </span>
   <span class="font10">Centers </span>
   <span class="font10">Chitnis </span>
   <span class="font10">Comi </span>
   <span class="font10">Düsseldorf, </span>
   <span class="font10">HVITD </span>
   <span class="font10">IFNb </span>
   <span class="font10">IL-β </span>
   <span class="font10">Increased </span>
   <span class="font10">Istanbul, </span>
   <span class="font10">Lake </span>
   <span class="font10">MI, </span>
   <span class="font10">MSKQ </span>
   <span class="font10">Mdn=., </span>
   <span class="font10">Mellen </span>
   <span class="font10">Mount </span>
   <span class="font10">Münster, </span>
   <span class="font10">Netherlands </span>
   <span class="font10">PET </span>
   <span class="font10">Quantitative </span>
   <span class="font10">RRMS, </span>
   <span class="font10">Russian </span>
   <span class="font10">Salt </span>
   <span class="font10">Strasbourg, </span>
   <span class="font10">Studies </span>
   <span class="font10">Switzerland </span>
   <span class="font10">TX, </span>
   <span class="font10">UT, </span>
   <span class="font10">Walton </span>
   <span class="font10">Wilcoxon </span>
   <span class="font10">achieved </span>
   <span class="font10">acquisition </span>
   <span class="font10">activities </span>
   <span class="font10">age-matched </span>
   <span class="font10">appeared </span>
   <span class="font10">approaches </span>
   <span class="font10">basal </span>
   <span class="font10">beginning </span>
   <span class="font10">benign </span>
   <span class="font10">blockade </span>
   <span class="font10">broad </span>
   <span class="font10">changes. </span>
   <span class="font10">computed </span>
   <span class="font10">confidence </span>
   <span class="font10">continuous </span>
   <span class="font10">contributes </span>
   <span class="font10">controlling </span>
   <span class="font10">criteria, </span>
   <span class="font10">culture </span>
   <span class="font10">cultures </span>
   <span class="font10">death </span>
   <span class="font10">decision </span>
   <span class="font10">deficits </span>
   <span class="font10">demonstrates </span>
   <span class="font10">depletion </span>
   <span class="font10">diagnosis. </span>
   <span class="font10">displayed </span>
   <span class="font10">echo </span>
   <span class="font10">endurance </span>
   <span class="font10">essential </span>
   <span class="font10">explained </span>
   <span class="font10">expression, </span>
   <span class="font10">female. </span>
   <span class="font10">fingolimod, </span>
   <span class="font10">focused </span>
   <span class="font10">fumarate </span>
   <span class="font10">glycosylated </span>
   <span class="font10">highest </span>
   <span class="font10">histological </span>
   <span class="font10">homologous </span>
   <span class="font10">i.e. </span>
   <span class="font10">implications </span>
   <span class="font10">infiltration </span>
   <span class="font10">injected </span>
   <span class="font10">injections </span>
   <span class="font10">innate </span>
   <span class="font10">integrity </span>
   <span class="font10">investigating </span>
   <span class="font10">involving </span>
   <span class="font10">latency </span>
   <span class="font10">layers </span>
   <span class="font10">lesion. </span>
   <span class="font10">level, </span>
   <span class="font10">light </span>
   <span class="font10">limb </span>
   <span class="font10">loading </span>
   <span class="font10">mass </span>
   <span class="font10">measures. </span>
   <span class="font10">men </span>
   <span class="font10">methylation </span>
   <span class="font10">modulate </span>
   <span class="font10">murine </span>
   <span class="font10">naive </span>
   <span class="font10">needs </span>
   <span class="font10">observations </span>
   <span class="font10">p=. </span>
   <span class="font10">p=., </span>
   <span class="font10">partially </span>
   <span class="font10">pathways. </span>
   <span class="font10">period, </span>
   <span class="font10">perivascular </span>
   <span class="font10">placebo. </span>
   <span class="font10">plasmablasts </span>
   <span class="font10">precursor </span>
   <span class="font10">presentation. </span>
   <span class="font10">prolonged-release </span>
   <span class="font10">propose </span>
   <span class="font10">psychosocial </span>
   <span class="font10">purpose </span>
   <span class="font10">quantification </span>
   <span class="font10">randomized, </span>
   <span class="font10">regions. </span>
   <span class="font10">registered </span>
   <span class="font10">reproductive </span>
   <span class="font10">requires </span>
   <span class="font10">respondents </span>
   <span class="font10">retrospectively </span>
   <span class="font10">rituximab </span>
   <span class="font10">score, </span>
   <span class="font10">self-reported </span>
   <span class="font10">seroconversion </span>
   <span class="font10">shift </span>
   <span class="font10">signs </span>
   <span class="font10">site </span>
   <span class="font10">size </span>
   <span class="font10">spatial </span>
   <span class="font10">standardized </span>
   <span class="font10">start </span>
   <span class="font10">started </span>
   <span class="font10">steroid </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">symptomatic </span>
   <span class="font10">symptoms. </span>
   <span class="font10">test, </span>
   <span class="font10">time. </span>
   <span class="font10">transplanted </span>
   <span class="font10">trials, </span>
   <span class="font10">unclear. </span>
   <span class="font10">used. </span>
   <span class="font10">validation </span>
   <span class="font10">vitro, </span>
   <span class="font10">vivo. </span>
   <span class="font10">working </span>
   <span class="font10">(GM) </span>
   <span class="font10">(median </span>
   <span class="font10">(r=−., </span>
   <span class="font10">.-point </span>
   <span class="font10">ACTIVE </span>
   <span class="font10">Assessment </span>
   <span class="font10">Aze </span>
   <span class="font10">B-cell </span>
   <span class="font10">CI: </span>
   <span class="font10">CNS, </span>
   <span class="font10">Cells </span>
   <span class="font10">Chicago, </span>
   <span class="font10">Detroit, </span>
   <span class="font10">EDSS. </span>
   <span class="font10">Early </span>
   <span class="font10">Hebron </span>
   <span class="font10">Heidelberg, </span>
   <span class="font10">IFNβ </span>
   <span class="font10">Izmir, </span>
   <span class="font10">Lee </span>
   <span class="font10">Madrid, </span>
   <span class="font10">NAbs </span>
   <span class="font10">NMOsd </span>
   <span class="font10">Neuroimmunology, </span>
   <span class="font10">Neuroradiology, </span>
   <span class="font10">OPC </span>
   <span class="font10">PCR </span>
   <span class="font10">Partners </span>
   <span class="font10">Pregnancy </span>
   <span class="font10">Republic, </span>
   <span class="font10">Rome, </span>
   <span class="font10">Serum </span>
   <span class="font10">Service </span>
   <span class="font10">South </span>
   <span class="font10">Subjects </span>
   <span class="font10">TCR </span>
   <span class="font10">Thus, </span>
   <span class="font10">Universitario </span>
   <span class="font10">Week </span>
   <span class="font10">Young </span>
   <span class="font10">Zagreb, </span>
   <span class="font10">Zurich, </span>
   <span class="font10">accuracy </span>
   <span class="font10">acid </span>
   <span class="font10">adaptive </span>
   <span class="font10">alternative </span>
   <span class="font10">assays. </span>
   <span class="font10">assessed. </span>
   <span class="font10">astrocytes. </span>
   <span class="font10">cerebellar </span>
   <span class="font10">chain </span>
   <span class="font10">cohorts </span>
   <span class="font10">comprehensive </span>
   <span class="font10">continued </span>
   <span class="font10">contribution </span>
   <span class="font10">coping </span>
   <span class="font10">cultured </span>
   <span class="font10">detailed </span>
   <span class="font10">determining </span>
   <span class="font10">deviation </span>
   <span class="font10">difficult </span>
   <span class="font10">diffuse </span>
   <span class="font10">double-blind, </span>
   <span class="font10">education </span>
   <span class="font10">effectiveness </span>
   <span class="font10">employment </span>
   <span class="font10">epigenetic </span>
   <span class="font10">establish </span>
   <span class="font10">evaluated. </span>
   <span class="font10">exchange </span>
   <span class="font10">expressing </span>
   <span class="font10">falling </span>
   <span class="font10">fetal </span>
   <span class="font10">field </span>
   <span class="font10">foot </span>
   <span class="font10">function. </span>
   <span class="font10">glycosylation </span>
   <span class="font10">impacts </span>
   <span class="font10">inhibitory </span>
   <span class="font10">insight </span>
   <span class="font10">intervals </span>
   <span class="font10">inversion </span>
   <span class="font10">issues </span>
   <span class="font10">levels. </span>
   <span class="font10">live </span>
   <span class="font10">localization </span>
   <span class="font10">location </span>
   <span class="font10">macrophages </span>
   <span class="font10">make </span>
   <span class="font10">maturation </span>
   <span class="font10">mature </span>
   <span class="font10">metabolism </span>
   <span class="font10">migratory </span>
   <span class="font10">n=) </span>
   <span class="font10">nature </span>
   <span class="font10">neuritis, </span>
   <span class="font10">newly </span>
   <span class="font10">non-responders </span>
   <span class="font10">nuclear </span>
   <span class="font10">outcomes. </span>
   <span class="font10">paired </span>
   <span class="font10">parallel </span>
   <span class="font10">participate </span>
   <span class="font10">participated </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">plasmapheresis </span>
   <span class="font10">plays </span>
   <span class="font10">post-mortem </span>
   <span class="font10">postural </span>
   <span class="font10">pre- </span>
   <span class="font10">prescribed </span>
   <span class="font10">prevent </span>
   <span class="font10">prevents </span>
   <span class="font10">primarily </span>
   <span class="font10">protocol </span>
   <span class="font10">psychometric </span>
   <span class="font10">questionnaires </span>
   <span class="font10">ranged </span>
   <span class="font10">ranging </span>
   <span class="font10">reactivity </span>
   <span class="font10">recognition </span>
   <span class="font10">reduces </span>
   <span class="font10">reference </span>
   <span class="font10">regions, </span>
   <span class="font10">regulate </span>
   <span class="font10">reliability </span>
   <span class="font10">remain </span>
   <span class="font10">reports </span>
   <span class="font10">respectively, </span>
   <span class="font10">responses. </span>
   <span class="font10">results. </span>
   <span class="font10">rsFC </span>
   <span class="font10">scales </span>
   <span class="font10">scored </span>
   <span class="font10">severity. </span>
   <span class="font10">stronger </span>
   <span class="font10">subgroup </span>
   <span class="font10">suggestive </span>
   <span class="font10">tasks </span>
   <span class="font10">techniques </span>
   <span class="font10">timed </span>
   <span class="font10">treatments. </span>
   <span class="font10">trends </span>
   <span class="font10">unknown </span>
   <span class="font10">usually </span>
   <span class="font10">validate </span>
   <span class="font10">validity </span>
   <span class="font10">version </span>
   <span class="font10">visits </span>
   <span class="font10">volume, </span>
   <span class="font10">whole-brain </span>
   <span class="font10">wide </span>
   <span class="font10">(CSF) </span>
   <span class="font10">(EDSS). </span>
   <span class="font10">(HC). </span>
   <span class="font10">(OH)D </span>
   <span class="font10">(P&amp;lt; </span>
   <span class="font10">(p= </span>
   <span class="font10">(range: </span>
   <span class="font10">-), </span>
   <span class="font10">AQP </span>
   <span class="font10">Ankara, </span>
   <span class="font10">Baltimore, </span>
   <span class="font10">Bethesda, </span>
   <span class="font10">CDL </span>
   <span class="font10">CHIL </span>
   <span class="font10">CIS, </span>
   <span class="font10">Comprehensive </span>
   <span class="font10">Core </span>
   <span class="font10">Day </span>
   <span class="font10">Demographic </span>
   <span class="font10">Disorders </span>
   <span class="font10">ELISA. </span>
   <span class="font10">EMMPRIN </span>
   <span class="font10">Emilia, </span>
   <span class="font10">Eye </span>
   <span class="font10">FAT </span>
   <span class="font10">Following </span>
   <span class="font10">Foxp </span>
   <span class="font10">GPS </span>
   <span class="font10">Gallarate, </span>
   <span class="font10">Geneva, </span>
   <span class="font10">HLA </span>
   <span class="font10">ILR </span>
   <span class="font10">IPI </span>
   <span class="font10">International </span>
   <span class="font10">Japan </span>
   <span class="font10">Lodz, </span>
   <span class="font10">MLBG </span>
   <span class="font10">MRIs </span>
   <span class="font10">MS; </span>
   <span class="font10">Melbourne </span>
   <span class="font10">Mexico, </span>
   <span class="font10">Montreal </span>
   <span class="font10">NDC- </span>
   <span class="font10">NYU </span>
   <span class="font10">QRS </span>
   <span class="font10">Quality </span>
   <span class="font10">Recent </span>
   <span class="font10">Reggio </span>
   <span class="font10">Resonance </span>
   <span class="font10">SF-D </span>
   <span class="font10">Social </span>
   <span class="font10">Universitätsmedizin </span>
   <span class="font10">Women </span>
   <span class="font10">[.] </span>
   <span class="font10">activity, </span>
   <span class="font10">address </span>
   <span class="font10">age: </span>
   <span class="font10">agents </span>
   <span class="font10">antibody, </span>
   <span class="font10">anxiety, </span>
   <span class="font10">approximately </span>
   <span class="font10">aquaporin- </span>
   <span class="font10">asked </span>
   <span class="font10">assays </span>
   <span class="font10">attending </span>
   <span class="font10">baclofen </span>
   <span class="font10">basis </span>
   <span class="font10">brain, </span>
   <span class="font10">calculate </span>
   <span class="font10">caregivers </span>
   <span class="font10">characteristic </span>
   <span class="font10">cingulate </span>
   <span class="font10">clusters </span>
   <span class="font10">comprised </span>
   <span class="font10">concerning </span>
   <span class="font10">consisting </span>
   <span class="font10">containing </span>
   <span class="font10">content </span>
   <span class="font10">control. </span>
   <span class="font10">coordination </span>
   <span class="font10">corrected </span>
   <span class="font10">corresponding </span>
   <span class="font10">damage. </span>
   <span class="font10">data, </span>
   <span class="font10">date, </span>
   <span class="font10">decade </span>
   <span class="font10">deficient </span>
   <span class="font10">delay </span>
   <span class="font10">demyelination, </span>
   <span class="font10">despite </span>
   <span class="font10">detecting </span>
   <span class="font10">diagnoses </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">diet </span>
   <span class="font10">disseminated </span>
   <span class="font10">dysfunction. </span>
   <span class="font10">earlier </span>
   <span class="font10">efficacy. </span>
   <span class="font10">efficiency </span>
   <span class="font10">enrolled. </span>
   <span class="font10">evaluating </span>
   <span class="font10">evolution </span>
   <span class="font10">examination </span>
   <span class="font10">exclusively </span>
   <span class="font10">expert </span>
   <span class="font10">factors. </span>
   <span class="font10">failure </span>
   <span class="font10">fatigued </span>
   <span class="font10">fear </span>
   <span class="font10">fingolimod. </span>
   <span class="font10">fraction </span>
   <span class="font10">fully </span>
   <span class="font10">helper </span>
   <span class="font10">humanized </span>
   <span class="font10">identifying </span>
   <span class="font10">immature </span>
   <span class="font10">immunity </span>
   <span class="font10">immunoregulatory </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">informed </span>
   <span class="font10">infusions </span>
   <span class="font10">insufficient </span>
   <span class="font10">interim </span>
   <span class="font10">interventions </span>
   <span class="font10">kinematic </span>
   <span class="font10">limit </span>
   <span class="font10">maintenance </span>
   <span class="font10">making </span>
   <span class="font10">marked </span>
   <span class="font10">maximum </span>
   <span class="font10">measures, </span>
   <span class="font10">medial </span>
   <span class="font10">melatonin </span>
   <span class="font10">mg/kg </span>
   <span class="font10">microstructural </span>
   <span class="font10">minutes </span>
   <span class="font10">monitored </span>
   <span class="font10">myelination </span>
   <span class="font10">nodes </span>
   <span class="font10">non-MS </span>
   <span class="font10">old </span>
   <span class="font10">oligodendrocytes. </span>
   <span class="font10">oligodendroglial </span>
   <span class="font10">onabotA </span>
   <span class="font10">outpatient </span>
   <span class="font10">parenchymal </span>
   <span class="font10">partial </span>
   <span class="font10">participating </span>
   <span class="font10">pilot </span>
   <span class="font10">poorly </span>
   <span class="font10">prediction </span>
   <span class="font10">progenitor </span>
   <span class="font10">psychological </span>
   <span class="font10">qualitative </span>
   <span class="font10">reach </span>
   <span class="font10">reactions </span>
   <span class="font10">receive </span>
   <span class="font10">referred </span>
   <span class="font10">relapses, </span>
   <span class="font10">repertoire </span>
   <span class="font10">sections </span>
   <span class="font10">separated </span>
   <span class="font10">seropositivity </span>
   <span class="font10">showing </span>
   <span class="font10">sleepiness </span>
   <span class="font10">slice </span>
   <span class="font10">slightly </span>
   <span class="font10">software. </span>
   <span class="font10">spectral </span>
   <span class="font10">staining </span>
   <span class="font10">steroids </span>
   <span class="font10">studied. </span>
   <span class="font10">subcortical </span>
   <span class="font10">suppressive </span>
   <span class="font10">systems </span>
   <span class="font10">tests. </span>
   <span class="font10">tolerated </span>
   <span class="font10">tools </span>
   <span class="font10">tracts </span>
   <span class="font10">transcription </span>
   <span class="font10">transverse </span>
   <span class="font10">typically </span>
   <span class="font10">variation </span>
   <span class="font10">variety </span>
   <span class="font10">veins </span>
   <span class="font10">viability </span>
   <span class="font10">vitro. </span>
   <span class="font10">voxel </span>
   <span class="font10">µm, </span>
   <span class="font10">(%, </span>
   <span class="font10">(-. </span>
   <span class="font10">(ARR) </span>
   <span class="font10">(NAWM) </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(RNFL) </span>
   <span class="font10">(RRMS), </span>
   <span class="font10">(i.e. </span>
   <span class="font10">(p&amp;gt;.). </span>
   <span class="font10">(p=. </span>
   <span class="font10">-/- </span>
   <span class="font10">-CD, </span>
   <span class="font10">.-.) </span>
   <span class="font10">.-., </span>
   <span class="font10">.±.% </span>
   <span class="font10">AA-MS </span>
   <span class="font10">AL, </span>
   <span class="font10">AOU </span>
   <span class="font10">Bar-Or </span>
   <span class="font10">Belgium, </span>
   <span class="font10">CD. </span>
   <span class="font10">CDMS </span>
   <span class="font10">CMI </span>
   <span class="font10">COP </span>
   <span class="font10">California, </span>
   <span class="font10">Centro </span>
   <span class="font10">Changes </span>
   <span class="font10">Charité </span>
   <span class="font10">Community </span>
   <span class="font10">Dalfampridine </span>
   <span class="font10">Demyelinating </span>
   <span class="font10">Diagnostic </span>
   <span class="font10">EFNB </span>
   <span class="font10">Engineering, </span>
   <span class="font10">European </span>
   <span class="font10">FACS </span>
   <span class="font10">FSS </span>
   <span class="font10">Given </span>
   <span class="font10">Glatiramer </span>
   <span class="font10">Global </span>
   <span class="font10">HYP-treated </span>
   <span class="font10">IFN-g </span>
   <span class="font10">IL--producing </span>
   <span class="font10">ITB </span>
   <span class="font10">Image </span>
   <span class="font10">Immunology </span>
   <span class="font10">Institutes </span>
   <span class="font10">Iran, </span>
   <span class="font10">Islamic </span>
   <span class="font10">Leuven, </span>
   <span class="font10">Lille, </span>
   <span class="font10">Loma </span>
   <span class="font10">MBP </span>
   <span class="font10">MSIS- </span>
   <span class="font10">Mental </span>
   <span class="font10">Modena </span>
   <span class="font10">Montalban </span>
   <span class="font10">NZB </span>
   <span class="font10">Neurologie, </span>
   <span class="font10">Neuroscience </span>
   <span class="font10">Neurosurgery, </span>
   <span class="font10">North </span>
   <span class="font10">Nur </span>
   <span class="font10">Orbassano, </span>
   <span class="font10">P=.). </span>
   <span class="font10">PBVC </span>
   <span class="font10">PSIR </span>
   <span class="font10">Padova, </span>
   <span class="font10">QSM </span>
   <span class="font10">Raffaele, </span>
   <span class="font10">SPM </span>
   <span class="font10">SPMS. </span>
   <span class="font10">Samples </span>
   <span class="font10">Score </span>
   <span class="font10">Sexual </span>
   <span class="font10">Sheba </span>
   <span class="font10">Southern </span>
   <span class="font10">Spearman </span>
   <span class="font10">Spinal </span>
   <span class="font10">Statistical </span>
   <span class="font10">T-maps </span>
   <span class="font10">Tehran, </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Timed </span>
   <span class="font10">Traboulsee </span>
   <span class="font10">Turku, </span>
   <span class="font10">Universitari </span>
   <span class="font10">Wayne </span>
   <span class="font10">[.]; </span>
   <span class="font10">adaptation </span>
   <span class="font10">aggressive </span>
   <span class="font10">agreement </span>
   <span class="font10">allowed </span>
   <span class="font10">amplitude </span>
   <span class="font10">analyse </span>
   <span class="font10">apoptosis </span>
   <span class="font10">atrophy. </span>
   <span class="font10">autoimmunity. </span>
   <span class="font10">autonomic </span>
   <span class="font10">bands </span>
   <span class="font10">baseline. </span>
   <span class="font10">battery </span>
   <span class="font10">behavioral </span>
   <span class="font10">born </span>
   <span class="font10">causes </span>
   <span class="font10">ceralifimod </span>
   <span class="font10">childbearing </span>
   <span class="font10">cholesterol </span>
   <span class="font10">cluster </span>
   <span class="font10">commensal </span>
   <span class="font10">composition </span>
   <span class="font10">concerns </span>
   <span class="font10">consisted </span>
   <span class="font10">correct </span>
   <span class="font10">course, </span>
   <span class="font10">created </span>
   <span class="font10">cumulative </span>
   <span class="font10">cycles </span>
   <span class="font10">cytometry. </span>
   <span class="font10">dietary </span>
   <span class="font10">differentiated </span>
   <span class="font10">discontinuation. </span>
   <span class="font10">discuss </span>
   <span class="font10">disease-related </span>
   <span class="font10">diseases, </span>
   <span class="font10">donors. </span>
   <span class="font10">dosing </span>
   <span class="font10">duration. </span>
   <span class="font10">dysfunction, </span>
   <span class="font10">effects, </span>
   <span class="font10">elective </span>
   <span class="font10">end </span>
   <span class="font10">episodes </span>
   <span class="font10">evident </span>
   <span class="font10">experiencing </span>
   <span class="font10">fall </span>
   <span class="font10">females, </span>
   <span class="font10">found. </span>
   <span class="font10">generally </span>
   <span class="font10">guide </span>
   <span class="font10">heterogeneity </span>
   <span class="font10">hypothesize </span>
   <span class="font10">hypothesized </span>
   <span class="font10">improves </span>
   <span class="font10">infusion. </span>
   <span class="font10">insights </span>
   <span class="font10">inter-hemispheric </span>
   <span class="font10">interactions </span>
   <span class="font10">intracranial </span>
   <span class="font10">investigated. </span>
   <span class="font10">level. </span>
   <span class="font10">lipid </span>
   <span class="font10">living </span>
   <span class="font10">males </span>
   <span class="font10">malignancies </span>
   <span class="font10">matter. </span>
   <span class="font10">maximal </span>
   <span class="font10">miRNA </span>
   <span class="font10">minimally </span>
   <span class="font10">mode </span>
   <span class="font10">moderately </span>
   <span class="font10">nabilone </span>
   <span class="font10">natalizumab-treated </span>
   <span class="font10">natalizumab. </span>
   <span class="font10">obtain </span>
   <span class="font10">option </span>
   <span class="font10">outcome. </span>
   <span class="font10">outer </span>
   <span class="font10">pain, </span>
   <span class="font10">panel </span>
   <span class="font10">parameters. </span>
   <span class="font10">pathogenicity </span>
   <span class="font10">pediatric-onset </span>
   <span class="font10">pharmacological </span>
   <span class="font10">phenotypes </span>
   <span class="font10">position </span>
   <span class="font10">possibility </span>
   <span class="font10">post-hoc </span>
   <span class="font10">preclinical </span>
   <span class="font10">pregnancy, </span>
   <span class="font10">pregnancy. </span>
   <span class="font10">pregnant </span>
   <span class="font10">producing </span>
   <span class="font10">product </span>
   <span class="font10">profiling </span>
   <span class="font10">prominent </span>
   <span class="font10">promoting </span>
   <span class="font10">qPCR </span>
   <span class="font10">rTMS </span>
   <span class="font10">random </span>
   <span class="font10">rapidly </span>
   <span class="font10">rated </span>
   <span class="font10">rats </span>
   <span class="font10">real </span>
   <span class="font10">reconstitution </span>
   <span class="font10">recorded. </span>
   <span class="font10">region </span>
   <span class="font10">regulator </span>
   <span class="font10">relapse. </span>
   <span class="font10">repeated </span>
   <span class="font10">represented </span>
   <span class="font10">responder </span>
   <span class="font10">responsible </span>
   <span class="font10">risk. </span>
   <span class="font10">scan </span>
   <span class="font10">separate </span>
   <span class="font10">seronegative </span>
   <span class="font10">sessions </span>
   <span class="font10">setting. </span>
   <span class="font10">short-term </span>
   <span class="font10">signatures </span>
   <span class="font10">simple </span>
   <span class="font10">status. </span>
   <span class="font10">stimulated </span>
   <span class="font10">stratification </span>
   <span class="font10">structure </span>
   <span class="font10">structures </span>
   <span class="font10">subpial </span>
   <span class="font10">subscales </span>
   <span class="font10">successful </span>
   <span class="font10">suffer </span>
   <span class="font10">suffering </span>
   <span class="font10">swelling </span>
   <span class="font10">synaptic </span>
   <span class="font10">tertiary </span>
   <span class="font10">thalamus </span>
   <span class="font10">theoretical </span>
   <span class="font10">these, </span>
   <span class="font10">treat </span>
   <span class="font10">univariate </span>
   <span class="font10">up. </span>
   <span class="font10">users </span>
   <span class="font10">way </span>
   <span class="font10">weekly </span>
   <span class="font10">widely </span>
   <span class="font10">widespread </span>
   <span class="font10">year, </span>
   <span class="font10">years). </span>
   <span class="font10">zone </span>
   <span class="font10">(.%). </span>
   <span class="font10">(EAE). </span>
   <span class="font10">(MS </span>
   <span class="font10">(N=) </span>
   <span class="font10">(SP) </span>
   <span class="font10">(e.g., </span>
   <span class="font10">(n=); </span>
   <span class="font10">(p=,). </span>
   <span class="font10">-fold </span>
   <span class="font10">.±.) </span>
   <span class="font10">=.) </span>
   <span class="font10">AaR </span>
   <span class="font10">Achiron </span>
   <span class="font10">Aim </span>
   <span class="font10">Aviv, </span>
   <span class="font10">BFSM </span>
   <span class="font10">BMD </span>
   <span class="font10">Baker </span>
   <span class="font10">Barts </span>
   <span class="font10">Blood </span>
   <span class="font10">Brazil </span>
   <span class="font10">CCR </span>
   <span class="font10">CDP-choline </span>
   <span class="font10">CES-D </span>
   <span class="font10">CT, </span>
   <span class="font10">CXCL </span>
   <span class="font10">Care </span>
   <span class="font10">Catalonia, </span>
   <span class="font10">Cell </span>
   <span class="font10">Cornell </span>
   <span class="font10">DAN </span>
   <span class="font10">DAWM </span>
   <span class="font10">December </span>
   <span class="font10">Denmark, </span>
   <span class="font10">Departments </span>
   <span class="font10">Diseases, </span>
   <span class="font10">Dnaja </span>
   <span class="font10">Dresden, </span>
   <span class="font10">ECG </span>
   <span class="font10">Evaluation </span>
   <span class="font10">French </span>
   <span class="font10">Future </span>
   <span class="font10">GEMS </span>
   <span class="font10">GLUT </span>
   <span class="font10">Gene </span>
   <span class="font10">Gold </span>
   <span class="font10">HC. </span>
   <span class="font10">HUTT </span>
   <span class="font10">Higher </span>
   <span class="font10">Hoffmann-La </span>
   <span class="font10">Holy </span>
   <span class="font10">Hope </span>
   <span class="font10">IFN-gamma </span>
   <span class="font10">II, </span>
   <span class="font10">ISR </span>
   <span class="font10">Icahn </span>
   <span class="font10">Idec </span>
   <span class="font10">IgM </span>
   <span class="font10">Inventory </span>
   <span class="font10">LTFU </span>
   <span class="font10">Luigi </span>
   <span class="font10">MEP </span>
   <span class="font10">MS-specific </span>
   <span class="font10">Mainz, </span>
   <span class="font10">Mann-Whitney </span>
   <span class="font10">Maracaibo, </span>
   <span class="font10">Martinelli </span>
   <span class="font10">Mayo </span>
   <span class="font10">Miller </span>
   <span class="font10">NAWM. </span>
   <span class="font10">NPC </span>
   <span class="font10">Naples, </span>
   <span class="font10">Neuropathology, </span>
   <span class="font10">OND </span>
   <span class="font10">Optica </span>
   <span class="font10">Optical </span>
   <span class="font10">Outcome </span>
   <span class="font10">Paulo, </span>
   <span class="font10">Pearson </span>
   <span class="font10">Peripheral </span>
   <span class="font10">Psychology, </span>
   <span class="font10">PwMS </span>
   <span class="font10">RR-MS </span>
   <span class="font10">Rochester, </span>
   <span class="font10">SDP </span>
   <span class="font10">SEMAD </span>
   <span class="font10">SF- </span>
   <span class="font10">SPR </span>
   <span class="font10">Safety </span>
   <span class="font10">Sanofi </span>
   <span class="font10">Sassari, </span>
   <span class="font10">Scale, </span>
   <span class="font10">Sciences </span>
   <span class="font10">Sclerosis, </span>
   <span class="font10">Similar </span>
   <span class="font10">Sinai, </span>
   <span class="font10">Spasticity </span>
   <span class="font10">Square </span>
   <span class="font10">T-hypointense </span>
   <span class="font10">TNF-R </span>
   <span class="font10">Tesla </span>
   <span class="font10">Texas </span>
   <span class="font10">Therapy, </span>
   <span class="font10">Total </span>
   <span class="font10">Training </span>
   <span class="font10">Translational </span>
   <span class="font10">Understanding </span>
   <span class="font10">Venezuela, </span>
   <span class="font10">VitD </span>
   <span class="font10">WA, </span>
   <span class="font10">Walk </span>
   <span class="font10">Weinstock-Guttman </span>
   <span class="font10">abortions </span>
   <span class="font10">absolute </span>
   <span class="font10">accurate </span>
   <span class="font10">advanced </span>
   <span class="font10">aerobic </span>
   <span class="font10">age- </span>
   <span class="font10">agonist </span>
   <span class="font10">allele </span>
   <span class="font10">analog </span>
   <span class="font10">analyzed. </span>
   <span class="font10">and, </span>
   <span class="font10">antigens </span>
   <span class="font10">apoptotic </span>
   <span class="font10">assist </span>
   <span class="font10">autoimmunity </span>
   <span class="font10">autoreactive </span>
   <span class="font10">blinded </span>
   <span class="font10">carried </span>
   <span class="font10">chemokine </span>
   <span class="font10">classical </span>
   <span class="font10">clinicians </span>
   <span class="font10">cognition </span>
   <span class="font10">cohort, </span>
   <span class="font10">collection </span>
   <span class="font10">color </span>
   <span class="font10">compounds </span>
   <span class="font10">concern </span>
   <span class="font10">conditions, </span>
   <span class="font10">confocal </span>
   <span class="font10">considerable </span>
   <span class="font10">consistently </span>
   <span class="font10">contain </span>
   <span class="font10">context </span>
   <span class="font10">cord. </span>
   <span class="font10">corticospinal </span>
   <span class="font10">crucial </span>
   <span class="font10">date </span>
   <span class="font10">dependency </span>
   <span class="font10">determination </span>
   <span class="font10">discontinuation </span>
   <span class="font10">disorders, </span>
   <span class="font10">eligible </span>
   <span class="font10">elucidate </span>
   <span class="font10">employed </span>
   <span class="font10">enhancement </span>
   <span class="font10">enhances </span>
   <span class="font10">estrogen </span>
   <span class="font10">evaluation. </span>
   <span class="font10">exert </span>
   <span class="font10">explain </span>
   <span class="font10">explored </span>
   <span class="font10">exposure, </span>
   <span class="font10">extended </span>
   <span class="font10">facebook </span>
   <span class="font10">facilitate </span>
   <span class="font10">far </span>
   <span class="font10">fields </span>
   <span class="font10">fixed </span>
   <span class="font10">fractions </span>
   <span class="font10">frequency, </span>
   <span class="font10">function, </span>
   <span class="font10">functioning. </span>
   <span class="font10">glutathione </span>
   <span class="font10">groups: </span>
   <span class="font10">healthcare </span>
   <span class="font10">heterogeneous </span>
   <span class="font10">high-resolution </span>
   <span class="font10">homeostasis </span>
   <span class="font10">identified. </span>
   <span class="font10">immunized </span>
   <span class="font10">impairment, </span>
   <span class="font10">includes </span>
   <span class="font10">inclusion </span>
   <span class="font10">increased. </span>
   <span class="font10">indirect </span>
   <span class="font10">inferior </span>
   <span class="font10">inflammation, </span>
   <span class="font10">initiated </span>
   <span class="font10">intermediate </span>
   <span class="font10">kinetic </span>
   <span class="font10">knockout </span>
   <span class="font10">laquinimod </span>
   <span class="font10">large, </span>
   <span class="font10">latencies </span>
   <span class="font10">lesion, </span>
   <span class="font10">levels, </span>
   <span class="font10">limbs </span>
   <span class="font10">link </span>
   <span class="font10">logistic </span>
   <span class="font10">lost </span>
   <span class="font10">maintain </span>
   <span class="font10">manifestation </span>
   <span class="font10">mapping </span>
   <span class="font10">match </span>
   <span class="font10">medium </span>
   <span class="font10">meningeal </span>
   <span class="font10">mice, </span>
   <span class="font10">mixed </span>
   <span class="font10">mm; </span>
   <span class="font10">monthly </span>
   <span class="font10">myeloid </span>
   <span class="font10">natalizumab, </span>
   <span class="font10">neuritis. </span>
   <span class="font10">non-ambulatory </span>
   <span class="font10">normative </span>
   <span class="font10">optimal </span>
   <span class="font10">ovarian </span>
   <span class="font10">paraclinical </span>
   <span class="font10">participant </span>
   <span class="font10">partners </span>
   <span class="font10">patient. </span>
   <span class="font10">phases </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">placebo-treated </span>
   <span class="font10">planned </span>
   <span class="font10">platform </span>
   <span class="font10">plus </span>
   <span class="font10">pooled </span>
   <span class="font10">posterior </span>
   <span class="font10">potassium </span>
   <span class="font10">presented. </span>
   <span class="font10">prevalent </span>
   <span class="font10">probably </span>
   <span class="font10">process. </span>
   <span class="font10">produced </span>
   <span class="font10">products </span>
   <span class="font10">prognostic </span>
   <span class="font10">project </span>
   <span class="font10">promoted </span>
   <span class="font10">providing </span>
   <span class="font10">px; </span>
   <span class="font10">rate, </span>
   <span class="font10">reached </span>
   <span class="font10">reaction </span>
   <span class="font10">recruited. </span>
   <span class="font10">reductions </span>
   <span class="font10">refractory </span>
   <span class="font10">regeneration </span>
   <span class="font10">relaxation </span>
   <span class="font10">remaining </span>
   <span class="font10">reserve </span>
   <span class="font10">results, </span>
   <span class="font10">retina </span>
   <span class="font10">revised </span>
   <span class="font10">risks </span>
   <span class="font10">samples. </span>
   <span class="font10">scanned </span>
   <span class="font10">scoring </span>
   <span class="font10">seizure </span>
   <span class="font10">self </span>
   <span class="font10">seven </span>
   <span class="font10">shorter </span>
   <span class="font10">slowly </span>
   <span class="font10">smaller </span>
   <span class="font10">solid </span>
   <span class="font10">source </span>
   <span class="font10">space </span>
   <span class="font10">spasticity. </span>
   <span class="font10">specificity </span>
   <span class="font10">speed, </span>
   <span class="font10">strategy </span>
   <span class="font10">supernatants </span>
   <span class="font10">suppression </span>
   <span class="font10">targeting </span>
   <span class="font10">tensor </span>
   <span class="font10">therapies. </span>
   <span class="font10">therapy, </span>
   <span class="font10">titer </span>
   <span class="font10">traditional </span>
   <span class="font10">tumefactive </span>
   <span class="font10">understood. </span>
   <span class="font10">variables. </span>
   <span class="font10">ventricle </span>
   <span class="font10">washout </span>
   <span class="font10">weight </span>
   <span class="font10">year. </span>
   <span class="font10">{font-family </span>
   <span class="font10">β-a </span>
   <span class="font10">(.%, </span>
   <span class="font10">(.±., </span>
   <span class="font10">(CIS) </span>
   <span class="font10">(CIS). </span>
   <span class="font10">(DMT) </span>
   <span class="font10">(DMTs) </span>
   <span class="font10">(FTY) </span>
   <span class="font10">(HR </span>
   <span class="font10">(IFN) </span>
   <span class="font10">(M) </span>
   <span class="font10">(MSWS-) </span>
   <span class="font10">(SPMS) </span>
   <span class="font10">(T) </span>
   <span class="font10">(e.g. </span>
   <span class="font10">(i.e., </span>
   <span class="font10">(including </span>
   <span class="font10">(r=.,p=.), </span>
   <span class="font10">.%) </span>
   <span class="font10">.-. </span>
   <span class="font10">.mm </span>
   <span class="font10">=.). </span>
   <span class="font10">APC </span>
   <span class="font10">Acute </span>
   <span class="font10">Aires, </span>
   <span class="font10">Alemtuzumab </span>
   <span class="font10">Anti-JCV </span>
   <span class="font10">Australia </span>
   <span class="font10">BCVA </span>
   <span class="font10">BID </span>
   <span class="font10">BMT </span>
   <span class="font10">Bari, </span>
   <span class="font10">Baylor </span>
   <span class="font10">Biology </span>
   <span class="font10">Biostatistics, </span>
   <span class="font10">Bristol, </span>
   <span class="font10">Buenos </span>
   <span class="font10">CBL/ </span>
   <span class="font10">CDCD </span>
   <span class="font10">CDDC </span>
   <span class="font10">CLARITY </span>
   <span class="font10">CST </span>
   <span class="font10">Clínico </span>
   <span class="font10">Company, </span>
   <span class="font10">Comparison </span>
   <span class="font10">Control </span>
   <span class="font10">Copaxone® </span>
   <span class="font10">Cortical </span>
   <span class="font10">DKB </span>
   <span class="font10">DMDs </span>
   <span class="font10">Del </span>
   <span class="font10">Denmark </span>
   <span class="font10">Descriptive </span>
   <span class="font10">Development </span>
   <span class="font10">Differential </span>
   <span class="font10">Dnajb </span>
   <span class="font10">EAE, </span>
   <span class="font10">EUReMS </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Expression </span>
   <span class="font10">FAMPKIN </span>
   <span class="font10">FLS </span>
   <span class="font10">FM- </span>
   <span class="font10">Fernández </span>
   <span class="font10">Genzyme, </span>
   <span class="font10">GlaxoSmithKline, </span>
   <span class="font10">Graduate </span>
   <span class="font10">Graves </span>
   <span class="font10">Group, </span>
   <span class="font10">Hopkins </span>
   <span class="font10">Houston, </span>
   <span class="font10">IARs </span>
   <span class="font10">IL-R </span>
   <span class="font10">INACTIVE </span>
   <span class="font10">Information </span>
   <span class="font10">Istanbul </span>
   <span class="font10">Johns </span>
   <span class="font10">LONMOSD </span>
   <span class="font10">LUTS </span>
   <span class="font10">Laquinimod </span>
   <span class="font10">Larger </span>
   <span class="font10">Louis, </span>
   <span class="font10">Lower </span>
   <span class="font10">MB, </span>
   <span class="font10">MCS </span>
   <span class="font10">MO, </span>
   <span class="font10">MPRAGE </span>
   <span class="font10">Manitoba, </span>
   <span class="font10">Maraviroc </span>
   <span class="font10">Massachusetts </span>
   <span class="font10">Max </span>
   <span class="font10">Motor </span>
   <span class="font10">Muenster, </span>
   <span class="font10">Multivariate </span>
   <span class="font10">MusiQol </span>
   <span class="font10">MyD </span>
   <span class="font10">NSAID </span>
   <span class="font10">Nervous </span>
   <span class="font10">Ness </span>
   <span class="font10">Neuroradiology </span>
   <span class="font10">No-OAB </span>
   <span class="font10">Norway, </span>
   <span class="font10">ONHV </span>
   <span class="font10">Oslo, </span>
   <span class="font10">P=.) </span>
   <span class="font10">PCS </span>
   <span class="font10">PLUS </span>
   <span class="font10">PROs </span>
   <span class="font10">Pathology </span>
   <span class="font10">Prevalence </span>
   <span class="font10">RGCs </span>
   <span class="font10">Regarding </span>
   <span class="font10">Rehabilitation, </span>
   <span class="font10">Relapsing </span>
   <span class="font10">Retinal </span>
   <span class="font10">SDMT </span>
   <span class="font10">SPMS, </span>
   <span class="font10">SWI </span>
   <span class="font10">Santa </span>
   <span class="font10">Sclerosi </span>
   <span class="font10">Seattle, </span>
   <span class="font10">Short </span>
   <span class="font10">Sick </span>
   <span class="font10">Similarly, </span>
   <span class="font10">Spearman’s </span>
   <span class="font10">São </span>
   <span class="font10">T*-weighted </span>
   <span class="font10">T:%±; </span>
   <span class="font10">TEMRA </span>
   <span class="font10">TNF </span>
   <span class="font10">Therapy </span>
   <span class="font10">Tokyo, </span>
   <span class="font10">Tregs. </span>
   <span class="font10">UCL </span>
   <span class="font10">Unit </span>
   <span class="font10">VEMP </span>
   <span class="font10">VZV </span>
   <span class="font10">Virgen </span>
   <span class="font10">Washington </span>
   <span class="font10">Weill </span>
   <span class="font10">Wii </span>
   <span class="font10">Winnipeg, </span>
   <span class="font10">[.-.], </span>
   <span class="font10">abortion </span>
   <span class="font10">age. </span>
   <span class="font10">alemtuzumab-treated </span>
   <span class="font10">algorithm </span>
   <span class="font10">allowing </span>
   <span class="font10">alter </span>
   <span class="font10">analysed. </span>
   <span class="font10">analyses, </span>
   <span class="font10">appearance </span>
   <span class="font10">applying </span>
   <span class="font10">approach. </span>
   <span class="font10">arrays </span>
   <span class="font10">automated </span>
   <span class="font10">axis </span>
   <span class="font10">behavior </span>
   <span class="font10">binds </span>
   <span class="font10">boys </span>
   <span class="font10">breastfed </span>
   <span class="font10">calculated. </span>
   <span class="font10">capacity. </span>
   <span class="font10">carrying </span>
   <span class="font10">case-control </span>
   <span class="font10">cases. </span>
   <span class="font10">centres </span>
   <span class="font10">channels </span>
   <span class="font10">characteristics, </span>
   <span class="font10">characterizing </span>
   <span class="font10">cladribine </span>
   <span class="font10">clarify </span>
   <span class="font10">clear </span>
   <span class="font10">clearly </span>
   <span class="font10">clinic. </span>
   <span class="font10">closed </span>
   <span class="font10">collagen </span>
   <span class="font10">communication </span>
   <span class="font10">conditional </span>
   <span class="font10">consistency </span>
   <span class="font10">continue </span>
   <span class="font10">contrast-enhanced </span>
   <span class="font10">correction </span>
   <span class="font10">correlation. </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">cost </span>
   <span class="font10">countries </span>
   <span class="font10">curves </span>
   <span class="font10">cutoff </span>
   <span class="font10">cutting </span>
   <span class="font10">cycle </span>
   <span class="font10">death. </span>
   <span class="font10">deficit </span>
   <span class="font10">definition </span>
   <span class="font10">degradation </span>
   <span class="font10">delayed </span>
   <span class="font10">demographic, </span>
   <span class="font10">demographics, </span>
   <span class="font10">detrusor </span>
   <span class="font10">development. </span>
   <span class="font10">differed </span>
   <span class="font10">diffusivity </span>
   <span class="font10">disruption </span>
   <span class="font10">distance </span>
   <span class="font10">documented </span>
   <span class="font10">dpt </span>
   <span class="font10">dysregulated </span>
   <span class="font10">effect. </span>
   <span class="font10">effectively </span>
   <span class="font10">effects. </span>
   <span class="font10">efficacy, </span>
   <span class="font10">elevation </span>
   <span class="font10">endpoint </span>
   <span class="font10">endpoints </span>
   <span class="font10">energy </span>
   <span class="font10">enrollment </span>
   <span class="font10">estimating </span>
   <span class="font10">estimation </span>
   <span class="font10">excitotoxic </span>
   <span class="font10">exclusion </span>
   <span class="font10">exhibit </span>
   <span class="font10">expanding </span>
   <span class="font10">extend </span>
   <span class="font10">extracellular </span>
   <span class="font10">eyes. </span>
   <span class="font10">flows </span>
   <span class="font10">font-size </span>
   <span class="font10">force </span>
   <span class="font10">girls </span>
   <span class="font10">grown </span>
   <span class="font10">head </span>
   <span class="font10">headache </span>
   <span class="font10">heart </span>
   <span class="font10">histopathological </span>
   <span class="font10">imaging. </span>
   <span class="font10">implanted </span>
   <span class="font10">increasingly </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibits </span>
   <span class="font10">initially </span>
   <span class="font10">inner </span>
   <span class="font10">intensities </span>
   <span class="font10">interfere </span>
   <span class="font10">interviews </span>
   <span class="font10">invariant </span>
   <span class="font10">investigation </span>
   <span class="font10">investigation. </span>
   <span class="font10">ion </span>
   <span class="font10">junction </span>
   <span class="font10">kinase </span>
   <span class="font10">learning </span>
   <span class="font10">leukocyte </span>
   <span class="font10">located </span>
   <span class="font10">lowest </span>
   <span class="font10">macrophages/microglia </span>
   <span class="font10">male, </span>
   <span class="font10">matter, </span>
   <span class="font10">meet </span>
   <span class="font10">melanoma </span>
   <span class="font10">methylprednisolone </span>
   <span class="font10">microscopy </span>
   <span class="font10">minimal </span>
   <span class="font10">minute </span>
   <span class="font10">mobilization </span>
   <span class="font10">modalities </span>
   <span class="font10">monitor </span>
   <span class="font10">multi-center </span>
   <span class="font10">multicenter </span>
   <span class="font10">natalizumab-associated </span>
   <span class="font10">near </span>
   <span class="font10">necessary </span>
   <span class="font10">nerves </span>
   <span class="font10">netrin- </span>
   <span class="font10">networks </span>
   <span class="font10">neuroimaging </span>
   <span class="font10">neurologic </span>
   <span class="font10">neurologists </span>
   <span class="font10">neurons, </span>
   <span class="font10">neuroprotection </span>
   <span class="font10">new/enlarging </span>
   <span class="font10">non </span>
   <span class="font10">normally </span>
   <span class="font10">numeracy </span>
   <span class="font10">occurrence </span>
   <span class="font10">odds </span>
   <span class="font10">older </span>
   <span class="font10">oligodendrocytes, </span>
   <span class="font10">online </span>
   <span class="font10">overlap </span>
   <span class="font10">p=.. </span>
   <span class="font10">particular </span>
   <span class="font10">pathology. </span>
   <span class="font10">peptides </span>
   <span class="font10">perception </span>
   <span class="font10">perform </span>
   <span class="font10">performing </span>
   <span class="font10">persistent </span>
   <span class="font10">personal </span>
   <span class="font10">phase, </span>
   <span class="font10">phase. </span>
   <span class="font10">physiological </span>
   <span class="font10">pial </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">point. </span>
   <span class="font10">points. </span>
   <span class="font10">poorer </span>
   <span class="font10">populations. </span>
   <span class="font10">post-marketing </span>
   <span class="font10">post-treatment </span>
   <span class="font10">potent </span>
   <span class="font10">practice. </span>
   <span class="font10">pre-pubertal </span>
   <span class="font10">pre-treatment </span>
   <span class="font10">precise </span>
   <span class="font10">predicts </span>
   <span class="font10">probabilistic </span>
   <span class="font10">problems, </span>
   <span class="font10">processed </span>
   <span class="font10">progenitors </span>
   <span class="font10">prognosis </span>
   <span class="font10">progression, </span>
   <span class="font10">promising </span>
   <span class="font10">proportions </span>
   <span class="font10">pump </span>
   <span class="font10">rapid </span>
   <span class="font10">reasons </span>
   <span class="font10">reconstructed </span>
   <span class="font10">recording </span>
   <span class="font10">relapse, </span>
   <span class="font10">respectively) </span>
   <span class="font10">response, </span>
   <span class="font10">scale. </span>
   <span class="font10">segment </span>
   <span class="font10">segmented </span>
   <span class="font10">seizures </span>
   <span class="font10">serial </span>
   <span class="font10">severely </span>
   <span class="font10">severity, </span>
   <span class="font10">share </span>
   <span class="font10">significant. </span>
   <span class="font10">slower </span>
   <span class="font10">stimulus </span>
   <span class="font10">strongest </span>
   <span class="font10">structured </span>
   <span class="font10">subclinical </span>
   <span class="font10">subpopulations </span>
   <span class="font10">subscale </span>
   <span class="font10">subsequently </span>
   <span class="font10">subsets, </span>
   <span class="font10">subtypes </span>
   <span class="font10">subtypes. </span>
   <span class="font10">sufficient </span>
   <span class="font10">suitable </span>
   <span class="font10">supplement </span>
   <span class="font10">switch </span>
   <span class="font10">switched </span>
   <span class="font10">switching </span>
   <span class="font10">taking </span>
   <span class="font10">task. </span>
   <span class="font10">tended </span>
   <span class="font10">thought </span>
   <span class="font10">throughput </span>
   <span class="font10">tissue. </span>
   <span class="font10">tissues </span>
   <span class="font10">titers </span>
   <span class="font10">tolerance </span>
   <span class="font10">transcriptional </span>
   <span class="font10">transient </span>
   <span class="font10">tremor. </span>
   <span class="font10">trial. </span>
   <span class="font10">trigeminal </span>
   <span class="font10">tweets </span>
   <span class="font10">valuable </span>
   <span class="font10">volumetric </span>
   <span class="font10">volumetry </span>
   <span class="font10">warranted </span>
   <span class="font10">women. </span>
   <span class="font10">years), </span>
   <span class="font10">yielded </span>
   <span class="font10">young </span>
   <span class="font10">&amp;gt;% </span>
   <span class="font10">(.%; </span>
   <span class="font10">(.±.) </span>
   <span class="font10">(BBB) </span>
   <span class="font10">(CNS). </span>
   <span class="font10">(EDSS), </span>
   <span class="font10">(GA) </span>
   <span class="font10">(HRQoL) </span>
   <span class="font10">(NMOSD). </span>
   <span class="font10">(NTZ) </span>
   <span class="font10">(PBMCs) </span>
   <span class="font10">(PP) </span>
   <span class="font10">(SC) </span>
   <span class="font10">(TONiC) </span>
   <span class="font10">(Th) </span>
   <span class="font10">(age </span>
   <span class="font10">(from </span>
   <span class="font10">(no </span>
   <span class="font10">(ρ=−., </span>
   <span class="font10">-AP </span>
   <span class="font10">-months </span>
   <span class="font10">.%. </span>
   <span class="font10">.-.), </span>
   <span class="font10">.]. </span>
   <span class="font10">AEs </span>
   <span class="font10">AUC </span>
   <span class="font10">Advanced </span>
   <span class="font10">Affymetrix </span>
   <span class="font10">Anxiety </span>
   <span class="font10">Ashworth </span>
   <span class="font10">Associations </span>
   <span class="font10">Athens, </span>
   <span class="font10">August </span>
   <span class="font10">Aurora, </span>
   <span class="font10">Average </span>
   <span class="font10">Behavioral </span>
   <span class="font10">Belman </span>
   <span class="font10">Bergen, </span>
   <span class="font10">Biostatistics </span>
   <span class="font10">Bronx, </span>
   <span class="font10">Brown </span>
   <span class="font10">Buffalo </span>
   <span class="font10">Busan, </span>
   <span class="font10">CBV </span>
   <span class="font10">CLEC- </span>
   <span class="font10">Catania, </span>
   <span class="font10">Chemical </span>
   <span class="font10">Chieti, </span>
   <span class="font10">Children </span>
   <span class="font10">Cocco </span>
   <span class="font10">Cohen </span>
   <span class="font10">Colombo </span>
   <span class="font10">Colorado </span>
   <span class="font10">Columbus, </span>
   <span class="font10">Composite </span>
   <span class="font10">Conditions </span>
   <span class="font10">Copenhagen </span>
   <span class="font10">Copenhagen, </span>
   <span class="font10">Corona </span>
   <span class="font10">Cox </span>
   <span class="font10">D-ER </span>
   <span class="font10">DMN </span>
   <span class="font10">Dry-OAB </span>
   <span class="font10">EDSS: </span>
   <span class="font10">Education </span>
   <span class="font10">Epworth </span>
   <span class="font10">Erasmus </span>
   <span class="font10">F-MS </span>
   <span class="font10">FAMS </span>
   <span class="font10">FIN </span>
   <span class="font10">Federation, </span>
   <span class="font10">Filippi </span>
   <span class="font10">Flow </span>
   <span class="font10">Foley </span>
   <span class="font10">Formulation </span>
   <span class="font10">Further, </span>
   <span class="font10">GSH </span>
   <span class="font10">Gan, </span>
   <span class="font10">Genetics, </span>
   <span class="font10">Genova, </span>
   <span class="font10">German </span>
   <span class="font10">Gonzaga, </span>
   <span class="font10">Greater </span>
   <span class="font10">HGF </span>
   <span class="font10">HPT </span>
   <span class="font10">HRQoL, </span>
   <span class="font10">HRV </span>
   <span class="font10">Hamburg, </span>
   <span class="font10">Hartung </span>
   <span class="font10">Haven, </span>
   <span class="font10">Havrdova </span>
   <span class="font10">Human </span>
   <span class="font10">Hunter </span>
   <span class="font10">IL-. </span>
   <span class="font10">IRIS </span>
   <span class="font10">Identification </span>
   <span class="font10">Illinois </span>
   <span class="font10">Internal </span>
   <span class="font10">Investigation </span>
   <span class="font10">Josef </span>
   <span class="font10">Kansas </span>
   <span class="font10">Krupp </span>
   <span class="font10">Laboratory, </span>
   <span class="font10">Lesion </span>
   <span class="font10">MCID/RD </span>
   <span class="font10">MCT </span>
   <span class="font10">MEPs </span>
   <span class="font10">MRI-only </span>
   <span class="font10">MS-associated </span>
   <span class="font10">MTR, </span>
   <span class="font10">MWT </span>
   <span class="font10">Marrie </span>
   <span class="font10">Marrosu </span>
   <span class="font10">Mice </span>
   <span class="font10">Milano, </span>
   <span class="font10">Moore </span>
   <span class="font10">NAA </span>
   <span class="font10">NMO-related </span>
   <span class="font10">NMOSD. </span>
   <span class="font10">NTZ. </span>
   <span class="font10">Napoli, </span>
   <span class="font10">Natalizumab, </span>
   <span class="font10">Neuropsychiatric </span>
   <span class="font10">Neurosciences </span>
   <span class="font10">Newcastle, </span>
   <span class="font10">OCT, </span>
   <span class="font10">OGC </span>
   <span class="font10">Outcomes </span>
   <span class="font10">Overall, </span>
   <span class="font10">Oxford </span>
   <span class="font10">P=.), </span>
   <span class="font10">PASAT </span>
   <span class="font10">Palermo, </span>
   <span class="font10">Paul </span>
   <span class="font10">People </span>
   <span class="font10">Personality </span>
   <span class="font10">Phillips </span>
   <span class="font10">Physics </span>
   <span class="font10">Planck </span>
   <span class="font10">Primary </span>
   <span class="font10">Program, </span>
   <span class="font10">QoL, </span>
   <span class="font10">Quantification </span>
   <span class="font10">RNFLT </span>
   <span class="font10">ROC </span>
   <span class="font10">Ramat </span>
   <span class="font10">Rayleigh </span>
   <span class="font10">Recently, </span>
   <span class="font10">Retrospective </span>
   <span class="font10">Reuter </span>
   <span class="font10">Rituximab </span>
   <span class="font10">Rose </span>
   <span class="font10">Rotterdam, </span>
   <span class="font10">SCI </span>
   <span class="font10">SD-OCT </span>
   <span class="font10">SLF </span>
   <span class="font10">SMAD </span>
   <span class="font10">SP-dependent </span>
   <span class="font10">Scale- </span>
   <span class="font10">Scale. </span>
   <span class="font10">Science </span>
   <span class="font10">Section </span>
   <span class="font10">Selmaj </span>
   <span class="font10">Serial </span>
   <span class="font10">Siena, </span>
   <span class="font10">Sleepiness </span>
   <span class="font10">Society </span>
   <span class="font10">Sola </span>
   <span class="font10">Stanford </span>
   <span class="font10">Survey </span>
   <span class="font10">TCZ </span>
   <span class="font10">TONiC </span>
   <span class="font10">TUG </span>
   <span class="font10">Tennant </span>
   <span class="font10">Thomas </span>
   <span class="font10">Tissue </span>
   <span class="font10">Trajectories </span>
   <span class="font10">Utah, </span>
   <span class="font10">VAS </span>
   <span class="font10">Valencia, </span>
   <span class="font10">Valladolid, </span>
   <span class="font10">Van </span>
   <span class="font10">WM, </span>
   <span class="font10">Waubant </span>
   <span class="font10">Weiner </span>
   <span class="font10">Yale </span>
   <span class="font10">Yeshiva </span>
   <span class="font10">Ziemssen </span>
   <span class="font10">aHR </span>
   <span class="font10">access </span>
   <span class="font10">accompanied </span>
   <span class="font10">account </span>
   <span class="font10">acidic </span>
   <span class="font10">actions </span>
   <span class="font10">activations </span>
   <span class="font10">adequately </span>
   <span class="font10">ages </span>
   <span class="font10">al, </span>
   <span class="font10">allocated </span>
   <span class="font10">alpha </span>
   <span class="font10">ameliorate </span>
   <span class="font10">amplitudes </span>
   <span class="font10">analyses. </span>
   <span class="font10">anatomic </span>
   <span class="font10">anatomical </span>
   <span class="font10">angioplasticity </span>
   <span class="font10">antioxidant </span>
   <span class="font10">approach, </span>
   <span class="font10">appropriate </span>
   <span class="font10">assay. </span>
   <span class="font10">assessments </span>
   <span class="font10">astroglial </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">atlas </span>
   <span class="font10">atrophy, </span>
   <span class="font10">attenuated </span>
   <span class="font10">auto-Abs </span>
   <span class="font10">availability </span>
   <span class="font10">available. </span>
   <span class="font10">averaged </span>
   <span class="font10">background </span>
   <span class="font10">barriers </span>
   <span class="font10">bind </span>
   <span class="font10">births </span>
   <span class="font10">block </span>
   <span class="font10">blood. </span>
   <span class="font10">callosum. </span>
   <span class="font10">captured </span>
   <span class="font10">challenging </span>
   <span class="font10">changed </span>
   <span class="font10">chi-square </span>
   <span class="font10">childhood </span>
   <span class="font10">chose </span>
   <span class="font10">coefficient </span>
   <span class="font10">collect </span>
   <span class="font10">community </span>
   <span class="font10">comparative </span>
   <span class="font10">comprising </span>
   <span class="font10">concept </span>
   <span class="font10">concerned </span>
   <span class="font10">consecutively </span>
   <span class="font10">considering </span>
   <span class="font10">conspicuity </span>
   <span class="font10">construct </span>
   <span class="font10">contributed </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">countries. </span>
   <span class="font10">counts </span>
   <span class="font10">cranial </span>
   <span class="font10">curve </span>
   <span class="font10">damage, </span>
   <span class="font10">damaged </span>
   <span class="font10">databases </span>
   <span class="font10">days, </span>
   <span class="font10">declined </span>
   <span class="font10">deficiency </span>
   <span class="font10">delta </span>
   <span class="font10">depending </span>
   <span class="font10">depression. </span>
   <span class="font10">depressive </span>
   <span class="font10">direction </span>
   <span class="font10">discrete </span>
   <span class="font10">dissemination </span>
   <span class="font10">distinguishing </span>
   <span class="font10">distributed </span>
   <span class="font10">double; </span>
   <span class="font10">drawn </span>
   <span class="font10">drugs. </span>
   <span class="font10">dual </span>
   <span class="font10">dysfunctions </span>
   <span class="font10">egress </span>
   <span class="font10">emerging </span>
   <span class="font10">engage </span>
   <span class="font10">entry </span>
   <span class="font10">enzymes </span>
   <span class="font10">equal </span>
   <span class="font10">events. </span>
   <span class="font10">examining </span>
   <span class="font10">excellent </span>
   <span class="font10">excluded. </span>
   <span class="font10">eye </span>
   <span class="font10">eyes, </span>
   <span class="font10">fast </span>
   <span class="font10">feasible </span>
   <span class="font10">feeding </span>
   <span class="font10">female) </span>
   <span class="font10">fibrillary </span>
   <span class="font10">findings, </span>
   <span class="font10">fine </span>
   <span class="font10">fitness </span>
   <span class="font10">fold </span>
   <span class="font10">forming </span>
   <span class="font10">functioning, </span>
   <span class="font10">gadolinium-enhancing </span>
   <span class="font10">ganglia </span>
   <span class="font10">gender-matched </span>
   <span class="font10">glia </span>
   <span class="font10">goal </span>
   <span class="font10">great </span>
   <span class="font10">gyrus, </span>
   <span class="font10">hand </span>
   <span class="font10">health, </span>
   <span class="font10">hematopoietic </span>
   <span class="font10">high-dose </span>
   <span class="font10">hormone </span>
   <span class="font10">humoral </span>
   <span class="font10">idiopathic </span>
   <span class="font10">immunization </span>
   <span class="font10">in-vitro </span>
   <span class="font10">incontinence </span>
   <span class="font10">indices </span>
   <span class="font10">indirectly </span>
   <span class="font10">inducing </span>
   <span class="font10">influences </span>
   <span class="font10">influencing </span>
   <span class="font10">initiating </span>
   <span class="font10">injury, </span>
   <span class="font10">internal </span>
   <span class="font10">interval, </span>
   <span class="font10">invited </span>
   <span class="font10">involvement. </span>
   <span class="font10">involves </span>
   <span class="font10">kept </span>
   <span class="font10">killer </span>
   <span class="font10">life, </span>
   <span class="font10">localized </span>
   <span class="font10">lumbar </span>
   <span class="font10">lymphocytes. </span>
   <span class="font10">macrophage </span>
   <span class="font10">macula </span>
   <span class="font10">masks </span>
   <span class="font10">matrix </span>
   <span class="font10">men, </span>
   <span class="font10">men; </span>
   <span class="font10">metabolites </span>
   <span class="font10">microbiota </span>
   <span class="font10">microflora </span>
   <span class="font10">middle </span>
   <span class="font10">modality </span>
   <span class="font10">models. </span>
   <span class="font10">modification </span>
   <span class="font10">monophasic </span>
   <span class="font10">motion </span>
   <span class="font10">ms) </span>
   <span class="font10">myelin. </span>
   <span class="font10">myelination. </span>
   <span class="font10">national </span>
   <span class="font10">nationwide </span>
   <span class="font10">neurologist </span>
   <span class="font10">non-invasive </span>
   <span class="font10">noted </span>
   <span class="font10">numerous </span>
   <span class="font10">observational, </span>
   <span class="font10">observe </span>
   <span class="font10">observed, </span>
   <span class="font10">oligodendrogenesis </span>
   <span class="font10">opposed </span>
   <span class="font10">original </span>
   <span class="font10">parameter </span>
   <span class="font10">pathology, </span>
   <span class="font10">pathway. </span>
   <span class="font10">patient, </span>
   <span class="font10">percentages </span>
   <span class="font10">perfusion </span>
   <span class="font10">persisted </span>
   <span class="font10">perspective </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">phenotypic </span>
   <span class="font10">physicians </span>
   <span class="font10">possibly </span>
   <span class="font10">post-pubertal </span>
   <span class="font10">practices </span>
   <span class="font10">preserved </span>
   <span class="font10">probability </span>
   <span class="font10">processes. </span>
   <span class="font10">program. </span>
   <span class="font10">protocol. </span>
   <span class="font10">pwMS </span>
   <span class="font10">questionnaire. </span>
   <span class="font10">r=−., </span>
   <span class="font10">race, </span>
   <span class="font10">range: </span>
   <span class="font10">rank </span>
   <span class="font10">reason </span>
   <span class="font10">receptors. </span>
   <span class="font10">records </span>
   <span class="font10">recovered </span>
   <span class="font10">recurrence </span>
   <span class="font10">reflected </span>
   <span class="font10">reflects </span>
   <span class="font10">registry </span>
   <span class="font10">regulates </span>
   <span class="font10">rejection </span>
   <span class="font10">remyelinating </span>
   <span class="font10">repair. </span>
   <span class="font10">repeat </span>
   <span class="font10">reproducibility </span>
   <span class="font10">researchers </span>
   <span class="font10">responded </span>
   <span class="font10">returned </span>
   <span class="font10">reversible </span>
   <span class="font10">rho </span>
   <span class="font10">rodent </span>
   <span class="font10">sampling </span>
   <span class="font10">scanning </span>
   <span class="font10">scans. </span>
   <span class="font10">sclerosis, </span>
   <span class="font10">screen </span>
   <span class="font10">secondary-progressive </span>
   <span class="font10">sector </span>
   <span class="font10">selectively </span>
   <span class="font10">self-report </span>
   <span class="font10">sequences. </span>
   <span class="font10">services </span>
   <span class="font10">sexuality </span>
   <span class="font10">significant, </span>
   <span class="font10">slanDC </span>
   <span class="font10">sought </span>
   <span class="font10">spasticity, </span>
   <span class="font10">special </span>
   <span class="font10">strength </span>
   <span class="font10">subsets. </span>
   <span class="font10">substance </span>
   <span class="font10">successfully </span>
   <span class="font10">supports </span>
   <span class="font10">suppressed </span>
   <span class="font10">supratentorial </span>
   <span class="font10">surrogate </span>
   <span class="font10">survival. </span>
   <span class="font10">synthesis </span>
   <span class="font10">systematic </span>
   <span class="font10">tPA </span>
   <span class="font10">thymocytes </span>
   <span class="font10">together, </span>
   <span class="font10">tolerability </span>
   <span class="font10">toxic </span>
   <span class="font10">transcriptome </span>
   <span class="font10">transfected </span>
   <span class="font10">transporter </span>
   <span class="font10">treatment; </span>
   <span class="font10">tumor </span>
   <span class="font10">undergo </span>
   <span class="font10">underlie </span>
   <span class="font10">unexpected </span>
   <span class="font10">unidimensional </span>
   <span class="font10">unplanned </span>
   <span class="font10">upregulation </span>
   <span class="font10">variables, </span>
   <span class="font10">variants </span>
   <span class="font10">vector </span>
   <span class="font10">verbal </span>
   <span class="font10">volumes. </span>
   <span class="font10">volunteers </span>
   <span class="font10">voxel-wise </span>
   <span class="font10">weighted </span>
   <span class="font10">were: </span>
   <span class="font10">worry </span>
   <span class="font10">years: </span>
   <span class="font10">yrs </span>
   <span class="font10">&amp;gt;. </span>
   <span class="font10">(), </span>
   <span class="font10">(-). </span>
   <span class="font10">(.), </span>
   <span class="font10">(A: </span>
   <span class="font10">(AQP) </span>
   <span class="font10">(DTI) </span>
   <span class="font10">(HD) </span>
   <span class="font10">(IFNβ) </span>
   <span class="font10">(IRR=., </span>
   <span class="font10">(MFIS). </span>
   <span class="font10">(MSCs) </span>
   <span class="font10">(NMOSD) </span>
   <span class="font10">(NRS </span>
   <span class="font10">(ON). </span>
   <span class="font10">(OPC) </span>
   <span class="font10">(OPCs) </span>
   <span class="font10">(PR) </span>
   <span class="font10">(R=., </span>
   <span class="font10">(RMS) </span>
   <span class="font10">(Stride </span>
   <span class="font10">(TFW) </span>
   <span class="font10">(VEPs) </span>
   <span class="font10">(adjusted </span>
   <span class="font10">(age, </span>
   <span class="font10">(and </span>
   <span class="font10">(initial </span>
   <span class="font10">(rs= </span>
   <span class="font10">(the </span>
   <span class="font10">(which </span>
   <span class="font10">,%; </span>
   <span class="font10">-Foot </span>
   <span class="font10">-HPT </span>
   <span class="font10">ALS </span>
   <span class="font10">AZ, </span>
   <span class="font10">Academy, </span>
   <span class="font10">Addition </span>
   <span class="font10">Additional </span>
   <span class="font10">Alabama, </span>
   <span class="font10">Allergan, </span>
   <span class="font10">Amiens, </span>
   <span class="font10">Antel </span>
   <span class="font10">Assess </span>
   <span class="font10">Astrocytes </span>
   <span class="font10">Astronomy, </span>
   <span class="font10">Austria </span>
   <span class="font10">Aviv </span>
   <span class="font10">BPF </span>
   <span class="font10">Board </span>
   <span class="font10">Bonferroni </span>
   <span class="font10">Brookline, </span>
   <span class="font10">Butzkueven </span>
   <span class="font10">CAMMS </span>
   <span class="font10">CAU-MS </span>
   <span class="font10">CAU-MS. </span>
   <span class="font10">CD- </span>
   <span class="font10">CDCDhi, </span>
   <span class="font10">CIS. </span>
   <span class="font10">CLs </span>
   <span class="font10">CVS </span>
   <span class="font10">CYPA </span>
   <span class="font10">C]-PIB </span>
   <span class="font10">Caucasian </span>
   <span class="font10">Caucasians </span>
   <span class="font10">Center. </span>
   <span class="font10">Cho </span>
   <span class="font10">Chronic </span>
   <span class="font10">Ciccarelli </span>
   <span class="font10">Comabella </span>
   <span class="font10">Consortium </span>
   <span class="font10">Contrast </span>
   <span class="font10">Correlation </span>
   <span class="font10">Correlations </span>
   <span class="font10">CpGs </span>
   <span class="font10">Croatia, </span>
   <span class="font10">Cultures </span>
   <span class="font10">Current </span>
   <span class="font10">Cyt </span>
   <span class="font10">DMT. </span>
   <span class="font10">Dallas, </span>
   <span class="font10">Dentistry, </span>
   <span class="font10">Detailed </span>
   <span class="font10">Differences </span>
   <span class="font10">Diseases </span>
   <span class="font10">Dokuz </span>
   <span class="font10">Dynamic </span>
   <span class="font10">ECPA </span>
   <span class="font10">EMD </span>
   <span class="font10">Effects </span>
   <span class="font10">Epidemiology, </span>
   <span class="font10">Especially </span>
   <span class="font10">Evaluate </span>
   <span class="font10">Exercise </span>
   <span class="font10">Eylul </span>
   <span class="font10">FDA </span>
   <span class="font10">FOXP </span>
   <span class="font10">FTY, </span>
   <span class="font10">FTY. </span>
   <span class="font10">Focal </span>
   <span class="font10">Fondazione </span>
   <span class="font10">Fox </span>
   <span class="font10">FoxP </span>
   <span class="font10">GFAP </span>
   <span class="font10">Gallo </span>
   <span class="font10">Genetics </span>
   <span class="font10">Ghezzi </span>
   <span class="font10">Girona, </span>
   <span class="font10">Gorman </span>
   <span class="font10">Goyang, </span>
   <span class="font10">Gregorio </span>
   <span class="font10">H-P </span>
   <span class="font10">HCVA </span>
   <span class="font10">HERV </span>
   <span class="font10">Haifa, </span>
   <span class="font10">Healy </span>
   <span class="font10">Herbert </span>
   <span class="font10">Hopital </span>
   <span class="font10">Hôpital </span>
   <span class="font10">IAR </span>
   <span class="font10">IFNB-a </span>
   <span class="font10">IL-Rβγ </span>
   <span class="font10">IMT </span>
   <span class="font10">Immune </span>
   <span class="font10">Imperial </span>
   <span class="font10">Importantly, </span>
   <span class="font10">Improvement </span>
   <span class="font10">Investigators </span>
   <span class="font10">IwMS </span>
   <span class="font10">IwMS. </span>
   <span class="font10">Jefferson </span>
   <span class="font10">Johnson </span>
   <span class="font10">Jones </span>
   <span class="font10">Kasper </span>
   <span class="font10">Kister </span>
   <span class="font10">LEF </span>
   <span class="font10">Linda </span>
   <span class="font10">Linnebank </span>
   <span class="font10">Little </span>
   <span class="font10">Liu </span>
   <span class="font10">Londrina, </span>
   <span class="font10">Lourie </span>
   <span class="font10">MBP, </span>
   <span class="font10">MHC </span>
   <span class="font10">MOBILE </span>
   <span class="font10">MRSI </span>
   <span class="font10">MS) </span>
   <span class="font10">MSFC </span>
   <span class="font10">MTT </span>
   <span class="font10">MUCCA </span>
   <span class="font10">Mackay </span>
   <span class="font10">Microbiology </span>
   <span class="font10">Moiola </span>
   <span class="font10">Movement </span>
   <span class="font10">Multipla, </span>
   <span class="font10">Murcia, </span>
   <span class="font10">MusiQoL </span>
   <span class="font10">NARCOMS </span>
   <span class="font10">NC, </span>
   <span class="font10">NF-MS </span>
   <span class="font10">NFL-TBS.- </span>
   <span class="font10">NH, </span>
   <span class="font10">NIHR </span>
   <span class="font10">NMR </span>
   <span class="font10">NPWT </span>
   <span class="font10">NTZ, </span>
   <span class="font10">NTZ-treated </span>
   <span class="font10">NaCl </span>
   <span class="font10">Neuritis </span>
   <span class="font10">Neuro-QOL </span>
   <span class="font10">NeuroCure </span>
   <span class="font10">NeuroQuant </span>
   <span class="font10">Neurologic </span>
   <span class="font10">Neuropsychological </span>
   <span class="font10">OR= </span>
   <span class="font10">Obersteiner-Redlich </span>
   <span class="font10">Occupational </span>
   <span class="font10">Ohio </span>
   <span class="font10">Orange, </span>
   <span class="font10">P=.); </span>
   <span class="font10">PBs </span>
   <span class="font10">Pain </span>
   <span class="font10">Paris, </span>
   <span class="font10">Park </span>
   <span class="font10">Parma, </span>
   <span class="font10">Pathology, </span>
   <span class="font10">Peg </span>
   <span class="font10">Pharmacology, </span>
   <span class="font10">Poisson </span>
   <span class="font10">Poland </span>
   <span class="font10">Predictors </span>
   <span class="font10">Prolonged-release </span>
   <span class="font10">Puerta </span>
   <span class="font10">QOL, </span>
   <span class="font10">RGC </span>
   <span class="font10">RNFLT, </span>
   <span class="font10">RR, </span>
   <span class="font10">RTX </span>
   <span class="font10">Radiology </span>
   <span class="font10">Ramasamy </span>
   <span class="font10">Rating </span>
   <span class="font10">Rauscher </span>
   <span class="font10">Reich </span>
   <span class="font10">Reliability </span>
   <span class="font10">Risk </span>
   <span class="font10">Rocca </span>
   <span class="font10">Rodegher </span>
   <span class="font10">Rodriguez </span>
   <span class="font10">Rovira </span>
   <span class="font10">Ruhr </span>
   <span class="font10">SD) </span>
   <span class="font10">SNPs </span>
   <span class="font10">Selective </span>
   <span class="font10">Serono, </span>
   <span class="font10">Sex </span>
   <span class="font10">Sexuality </span>
   <span class="font10">Sheffield, </span>
   <span class="font10">Shin </span>
   <span class="font10">Sinai </span>
   <span class="font10">Specifically, </span>
   <span class="font10">Stanford, </span>
   <span class="font10">Stockholm, </span>
   <span class="font10">Stroke, </span>
   <span class="font10">Support </span>
   <span class="font10">Surgery, </span>
   <span class="font10">Sweden, </span>
   <span class="font10">Symptoms </span>
   <span class="font10">T--FW </span>
   <span class="font10">TCI </span>
   <span class="font10">TGF- </span>
   <span class="font10">TMS </span>
   <span class="font10">TMV </span>
   <span class="font10">TNF-a </span>
   <span class="font10">TRIF </span>
   <span class="font10">Taken </span>
   <span class="font10">Teaching </span>
   <span class="font10">Teaneck, </span>
   <span class="font10">Thessaloniki, </span>
   <span class="font10">Thompson </span>
   <span class="font10">Tintoré </span>
   <span class="font10">Tw, </span>
   <span class="font10">UBC </span>
   <span class="font10">UEF </span>
   <span class="font10">UI-Any </span>
   <span class="font10">UMR </span>
   <span class="font10">Universitätsklinikum </span>
   <span class="font10">Université </span>
   <span class="font10">Urbana-Champaign, </span>
   <span class="font10">VEP-ss </span>
   <span class="font10">Vavasour </span>
   <span class="font10">WI, </span>
   <span class="font10">Weber </span>
   <span class="font10">Weeks </span>
   <span class="font10">West </span>
   <span class="font10">YFP </span>
   <span class="font10">Yang </span>
   <span class="font10">Yeh </span>
   <span class="font10">Zhang </span>
   <span class="font10">Zhao </span>
   <span class="font10">Zivadinov </span>
   <span class="font10">[mean </span>
   <span class="font10">abrogated </span>
   <span class="font10">acetate. </span>
   <span class="font10">achieve </span>
   <span class="font10">activation, </span>
   <span class="font10">activation. </span>
   <span class="font10">actual </span>
   <span class="font10">added </span>
   <span class="font10">adding </span>
   <span class="font10">adhesion </span>
   <span class="font10">adjacent </span>
   <span class="font10">adjustment. </span>
   <span class="font10">alteration </span>
   <span class="font10">ameliorates </span>
   <span class="font10">angle </span>
   <span class="font10">anisotropy </span>
   <span class="font10">anti-IL- </span>
   <span class="font10">anti-JC </span>
   <span class="font10">anti-TNFa </span>
   <span class="font10">antibodies, </span>
   <span class="font10">antibodies. </span>
   <span class="font10">apparent </span>
   <span class="font10">aquaporin </span>
   <span class="font10">area, </span>
   <span class="font10">arrays. </span>
   <span class="font10">artificial </span>
   <span class="font10">assessment. </span>
   <span class="font10">assigned </span>
   <span class="font10">asthmatic </span>
   <span class="font10">astrogliosis </span>
   <span class="font10">asymmetry </span>
   <span class="font10">automatically </span>
   <span class="font10">awake </span>
   <span class="font10">awareness </span>
   <span class="font10">axons. </span>
   <span class="font10">bacteria </span>
   <span class="font10">before, </span>
   <span class="font10">behalf </span>
   <span class="font10">birth </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">breakdown </span>
   <span class="font10">brief </span>
   <span class="font10">callosal </span>
   <span class="font10">capable </span>
   <span class="font10">capture </span>
   <span class="font10">care. </span>
   <span class="font10">centers </span>
   <span class="font10">cerebellum </span>
   <span class="font10">changes, </span>
   <span class="font10">chart </span>
   <span class="font10">childlessness </span>
   <span class="font10">choice </span>
   <span class="font10">choose </span>
   <span class="font10">chromosomal </span>
   <span class="font10">class </span>
   <span class="font10">coefficients </span>
   <span class="font10">cognitively </span>
   <span class="font10">collected. </span>
   <span class="font10">combining </span>
   <span class="font10">comparisons. </span>
   <span class="font10">compartments </span>
   <span class="font10">complications </span>
   <span class="font10">compound </span>
   <span class="font10">conclude </span>
   <span class="font10">concluded </span>
   <span class="font10">conditions. </span>
   <span class="font10">consent </span>
   <span class="font10">considered. </span>
   <span class="font10">constant </span>
   <span class="font10">constitute </span>
   <span class="font10">constructs </span>
   <span class="font10">consumption </span>
   <span class="font10">contained </span>
   <span class="font10">contains </span>
   <span class="font10">continuing </span>
   <span class="font10">continuously </span>
   <span class="font10">contraception </span>
   <span class="font10">copy </span>
   <span class="font10">cords </span>
   <span class="font10">correlating </span>
   <span class="font10">counseling </span>
   <span class="font10">covering </span>
   <span class="font10">criterion </span>
   <span class="font10">culture-expanded </span>
   <span class="font10">cuprizone-induced </span>
   <span class="font10">custom </span>
   <span class="font10">cutaneous </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">datasets </span>
   <span class="font10">days. </span>
   <span class="font10">decisions </span>
   <span class="font10">decreasing </span>
   <span class="font10">deficits. </span>
   <span class="font10">define </span>
   <span class="font10">delays </span>
   <span class="font10">delivered </span>
   <span class="font10">depressed </span>
   <span class="font10">der </span>
   <span class="font10">described. </span>
   <span class="font10">description </span>
   <span class="font10">details </span>
   <span class="font10">detects </span>
   <span class="font10">device </span>
   <span class="font10">different. </span>
   <span class="font10">differentiation, </span>
   <span class="font10">differs </span>
   <span class="font10">difficulty </span>
   <span class="font10">directions </span>
   <span class="font10">disabilities </span>
   <span class="font10">discrimination </span>
   <span class="font10">distress </span>
   <span class="font10">document </span>
   <span class="font10">dominant </span>
   <span class="font10">draft </span>
   <span class="font10">dystonia </span>
   <span class="font10">earliest </span>
   <span class="font10">efforts </span>
   <span class="font10">electrophysiological </span>
   <span class="font10">eliminated </span>
   <span class="font10">emotional </span>
   <span class="font10">enhance </span>
   <span class="font10">enlargement </span>
   <span class="font10">enriched </span>
   <span class="font10">environment </span>
   <span class="font10">epitope </span>
   <span class="font10">equally </span>
   <span class="font10">errors </span>
   <span class="font10">ethnicity </span>
   <span class="font10">evolving </span>
   <span class="font10">exacerbation </span>
   <span class="font10">exact </span>
   <span class="font10">exclude </span>
   <span class="font10">exist </span>
   <span class="font10">exploring </span>
   <span class="font10">exposure. </span>
   <span class="font10">extending </span>
   <span class="font10">fMRI-TF </span>
   <span class="font10">fact </span>
   <span class="font10">fate </span>
   <span class="font10">feedback </span>
   <span class="font10">fewer </span>
   <span class="font10">fluorescent </span>
   <span class="font10">focus </span>
   <span class="font10">follows: </span>
   <span class="font10">formation </span>
   <span class="font10">fractional </span>
   <span class="font10">gain </span>
   <span class="font10">games </span>
   <span class="font10">generic </span>
   <span class="font10">genes, </span>
   <span class="font10">geometry </span>
   <span class="font10">gold </span>
   <span class="font10">gradient </span>
   <span class="font10">greatest </span>
   <span class="font10">gyrus </span>
   <span class="font10">health. </span>
   <span class="font10">helpful </span>
   <span class="font10">highlights </span>
   <span class="font10">hippocampus </span>
   <span class="font10">hospital </span>
   <span class="font10">hypoxia </span>
   <span class="font10">identified, </span>
   <span class="font10">images, </span>
   <span class="font10">immediately </span>
   <span class="font10">immunoglobulins </span>
   <span class="font10">immunomodulator </span>
   <span class="font10">immunoreactivity </span>
   <span class="font10">immunostained </span>
   <span class="font10">implemented </span>
   <span class="font10">improvement. </span>
   <span class="font10">incomplete </span>
   <span class="font10">indexes </span>
   <span class="font10">individualized </span>
   <span class="font10">individuals, </span>
   <span class="font10">infiltrating </span>
   <span class="font10">infiltration, </span>
   <span class="font10">inflammation-related </span>
   <span class="font10">infusion, </span>
   <span class="font10">intensive </span>
   <span class="font10">interference </span>
   <span class="font10">intervention. </span>
   <span class="font10">intra-retinal </span>
   <span class="font10">intracortical </span>
   <span class="font10">intrusiveness. </span>
   <span class="font10">inverse </span>
   <span class="font10">inversely </span>
   <span class="font10">kefyr </span>
   <span class="font10">kinematics </span>
   <span class="font10">kinetics </span>
   <span class="font10">known. </span>
   <span class="font10">largest </span>
   <span class="font10">laser </span>
   <span class="font10">late </span>
   <span class="font10">later. </span>
   <span class="font10">length, </span>
   <span class="font10">lesional </span>
   <span class="font10">lesions) </span>
   <span class="font10">leukocytes </span>
   <span class="font10">ligands </span>
   <span class="font10">limitations </span>
   <span class="font10">limited. </span>
   <span class="font10">limiting </span>
   <span class="font10">loaded </span>
   <span class="font10">mDCs </span>
   <span class="font10">machine </span>
   <span class="font10">male) </span>
   <span class="font10">malignancy </span>
   <span class="font10">manifestations </span>
   <span class="font10">manually </span>
   <span class="font10">maps. </span>
   <span class="font10">mediate </span>
   <span class="font10">mediates </span>
   <span class="font10">medication, </span>
   <span class="font10">menopause </span>
   <span class="font10">method. </span>
   <span class="font10">methylated </span>
   <span class="font10">mg/day </span>
   <span class="font10">microRNAs </span>
   <span class="font10">microbial </span>
   <span class="font10">microglial </span>
   <span class="font10">mild, </span>
   <span class="font10">million </span>
   <span class="font10">minimum </span>
   <span class="font10">minor </span>
   <span class="font10">missing </span>
   <span class="font10">modulating </span>
   <span class="font10">monocytes, </span>
   <span class="font10">months). </span>
   <span class="font10">mood </span>
   <span class="font10">movement </span>
   <span class="font10">multicenter, </span>
   <span class="font10">muscles </span>
   <span class="font10">mutation </span>
   <span class="font10">myelinating </span>
   <span class="font10">myelitis. </span>
   <span class="font10">n=), </span>
   <span class="font10">n=). </span>
   <span class="font10">n=; </span>
   <span class="font10">nabiximols </span>
   <span class="font10">necrosis </span>
   <span class="font10">nerve. </span>
   <span class="font10">neuroinflammation </span>
   <span class="font10">neurons. </span>
   <span class="font10">neuropsychiatric </span>
   <span class="font10">non-enhancing </span>
   <span class="font10">non-progressive </span>
   <span class="font10">obtaining </span>
   <span class="font10">offers </span>
   <span class="font10">open </span>
   <span class="font10">opportunity </span>
   <span class="font10">optimized </span>
   <span class="font10">orally </span>
   <span class="font10">outcomes, </span>
   <span class="font10">overactivity </span>
   <span class="font10">p=.); </span>
   <span class="font10">palliative </span>
   <span class="font10">participants, </span>
   <span class="font10">particular, </span>
   <span class="font10">patients; </span>
   <span class="font10">pension </span>
   <span class="font10">periods </span>
   <span class="font10">periphery </span>
   <span class="font10">permanent </span>
   <span class="font10">perpendicular </span>
   <span class="font10">person </span>
   <span class="font10">phenotype. </span>
   <span class="font10">place </span>
   <span class="font10">plasticity </span>
   <span class="font10">population-based </span>
   <span class="font10">positively </span>
   <span class="font10">positivity </span>
   <span class="font10">potential. </span>
   <span class="font10">predicting </span>
   <span class="font10">preferentially </span>
   <span class="font10">preservation </span>
   <span class="font10">preventing </span>
   <span class="font10">procedures </span>
   <span class="font10">process, </span>
   <span class="font10">producers </span>
   <span class="font10">profile. </span>
   <span class="font10">proportional </span>
   <span class="font10">protect </span>
   <span class="font10">prove </span>
   <span class="font10">providers </span>
   <span class="font10">providers. </span>
   <span class="font10">proximal </span>
   <span class="font10">putative </span>
   <span class="font10">pwRMS </span>
   <span class="font10">question </span>
   <span class="font10">radiographic </span>
   <span class="font10">rarely </span>
   <span class="font10">ratios </span>
   <span class="font10">re-myelination </span>
   <span class="font10">real-world </span>
   <span class="font10">recognize </span>
   <span class="font10">recombinant </span>
   <span class="font10">records. </span>
   <span class="font10">refine </span>
   <span class="font10">reflecting </span>
   <span class="font10">regardless </span>
   <span class="font10">regenerative </span>
   <span class="font10">registers </span>
   <span class="font10">registration </span>
   <span class="font10">regulating </span>
   <span class="font10">regulators </span>
   <span class="font10">relating </span>
   <span class="font10">reliably </span>
   <span class="font10">reorganization </span>
   <span class="font10">representative </span>
   <span class="font10">representing </span>
   <span class="font10">resolution, </span>
   <span class="font10">respectively), </span>
   <span class="font10">respond </span>
   <span class="font10">retention </span>
   <span class="font10">retrograde </span>
   <span class="font10">samples, </span>
   <span class="font10">scanner. </span>
   <span class="font10">scans, </span>
   <span class="font10">screened </span>
   <span class="font10">sensitively </span>
   <span class="font10">sequencing </span>
   <span class="font10">serve </span>
   <span class="font10">served </span>
   <span class="font10">service </span>
   <span class="font10">sex-matched </span>
   <span class="font10">shifts </span>
   <span class="font10">shock </span>
   <span class="font10">siblings </span>
   <span class="font10">signals </span>
   <span class="font10">signed </span>
   <span class="font10">skeletal </span>
   <span class="font10">smoking, </span>
   <span class="font10">solid; </span>
   <span class="font10">sorted </span>
   <span class="font10">stabilized </span>
   <span class="font10">stage. </span>
   <span class="font10">state. </span>
   <span class="font10">statistics </span>
   <span class="font10">stopped </span>
   <span class="font10">stratified </span>
   <span class="font10">strict </span>
   <span class="font10">submitted </span>
   <span class="font10">suitability </span>
   <span class="font10">sum </span>
   <span class="font10">supplementation </span>
   <span class="font10">supported </span>
   <span class="font10">supporting </span>
   <span class="font10">suppress </span>
   <span class="font10">suppressor </span>
   <span class="font10">surface. </span>
   <span class="font10">surviving </span>
   <span class="font10">suspected </span>
   <span class="font10">symbiont </span>
   <span class="font10">symptom. </span>
   <span class="font10">syndrome, </span>
   <span class="font10">t-test </span>
   <span class="font10">t-test. </span>
   <span class="font10">techniques. </span>
   <span class="font10">technology </span>
   <span class="font10">teriflunomide-treated </span>
   <span class="font10">termination </span>
   <span class="font10">testing. </span>
   <span class="font10">thalamotomy </span>
   <span class="font10">them, </span>
   <span class="font10">thereafter. </span>
   <span class="font10">thickness, </span>
   <span class="font10">this, </span>
   <span class="font10">thymic </span>
   <span class="font10">thyroid </span>
   <span class="font10">tight </span>
   <span class="font10">tolerogenic </span>
   <span class="font10">trained </span>
   <span class="font10">trajectory </span>
   <span class="font10">transcranial </span>
   <span class="font10">transition </span>
   <span class="font10">trimester </span>
   <span class="font10">type. </span>
   <span class="font10">undergoing </span>
   <span class="font10">unidimensionality </span>
   <span class="font10">unit </span>
   <span class="font10">unmet </span>
   <span class="font10">urodynamic </span>
   <span class="font10">utilized </span>
   <span class="font10">utilizing </span>
   <span class="font10">valid </span>
   <span class="font10">varied </span>
   <span class="font10">vary </span>
   <span class="font10">vein </span>
   <span class="font10">ventricular </span>
   <span class="font10">viability. </span>
   <span class="font10">visit, </span>
   <span class="font10">visit. </span>
   <span class="font10">volume) </span>
   <span class="font10">volume. </span>
   <span class="font10">von </span>
   <span class="font10">walking, </span>
   <span class="font10">weakly </span>
   <span class="font10">weeks, </span>
   <span class="font10">wild </span>
   <span class="font10">writing </span>
   <span class="font10">yeast </span>
   <span class="font10">yield </span>
   <span class="font10">z-score </span>
   <span class="font10">z=−., </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">"invisible" </span>
   <span class="font10">(). </span>
   <span class="font10">(-%) </span>
   <span class="font10">(-%). </span>
   <span class="font10">(.). </span>
   <span class="font10">(.-.) </span>
   <span class="font10">(ADEM) </span>
   <span class="font10">(AEs) </span>
   <span class="font10">(BID/BID, </span>
   <span class="font10">(CD </span>
   <span class="font10">(CRESM), </span>
   <span class="font10">(DIR) </span>
   <span class="font10">(DMF) </span>
   <span class="font10">(IL-β) </span>
   <span class="font10">(JCV) </span>
   <span class="font10">(MAIT) </span>
   <span class="font10">(MBP) </span>
   <span class="font10">(MR) </span>
   <span class="font10">(NMO). </span>
   <span class="font10">(ON), </span>
   <span class="font10">(PBMC) </span>
   <span class="font10">(PCS) </span>
   <span class="font10">(PET) </span>
   <span class="font10">(QoL) </span>
   <span class="font10">(QoL). </span>
   <span class="font10">(R) </span>
   <span class="font10">(SD-OCT) </span>
   <span class="font10">(SIR </span>
   <span class="font10">(T:%±%; </span>
   <span class="font10">(T:%±; </span>
   <span class="font10">(TP, </span>
   <span class="font10">(Treg) </span>
   <span class="font10">(at </span>
   <span class="font10">(defined </span>
   <span class="font10">(df </span>
   <span class="font10">(eyes </span>
   <span class="font10">(mean±SD) </span>
   <span class="font10">(odds </span>
   <span class="font10">(p=,), </span>
   <span class="font10">(pwMS). </span>
   <span class="font10">(r= </span>
   <span class="font10">(r=.,p&amp;lt; </span>
   <span class="font10">(r=.~., </span>
   <span class="font10">(total </span>
   <span class="font10">(with </span>
   <span class="font10">(β=., </span>
   <span class="font10">,). </span>
   <span class="font10">--specific </span>
   <span class="font10">-.% </span>
   <span class="font10">-.) </span>
   <span class="font10">-.), </span>
   <span class="font10">-THC </span>
   <span class="font10">-hour </span>
   <span class="font10">-hydroxyvitamin </span>
   <span class="font10">-point </span>
   <span class="font10">-year-old </span>
   <span class="font10">.%). </span>
   <span class="font10">.]), </span>
   <span class="font10">.]). </span>
   <span class="font10">.], </span>
   <span class="font10">.±.%, </span>
   <span class="font10">.±.. </span>
   <span class="font10">/ul </span>
   <span class="font10">AHSCT </span>
   <span class="font10">ANOVAs </span>
   <span class="font10">AONMOSD </span>
   <span class="font10">API </span>
   <span class="font10">ARG </span>
   <span class="font10">ASCEND </span>
   <span class="font10">Aaen </span>
   <span class="font10">Alabama </span>
   <span class="font10">Altered </span>
   <span class="font10">Amato </span>
   <span class="font10">Analyzing </span>
   <span class="font10">Antibody </span>
   <span class="font10">Argentina, </span>
   <span class="font10">Arnold </span>
   <span class="font10">Auger </span>
   <span class="font10">BAEP </span>
   <span class="font10">BIIB </span>
   <span class="font10">BMSC </span>
   <span class="font10">Bain </span>
   <span class="font10">Banwell </span>
   <span class="font10">Bao </span>
   <span class="font10">Belgium </span>
   <span class="font10">Benson </span>
   <span class="font10">Bergsland </span>
   <span class="font10">Bertolotto </span>
   <span class="font10">Besides, </span>
   <span class="font10">Between-group </span>
   <span class="font10">Bilim </span>
   <span class="font10">Billerica, </span>
   <span class="font10">Blizard </span>
   <span class="font10">Boneschi </span>
   <span class="font10">Boston </span>
   <span class="font10">Bowel </span>
   <span class="font10">Brook </span>
   <span class="font10">Bruce </span>
   <span class="font10">Brunswick, </span>
   <span class="font10">Brück </span>
   <span class="font10">CD-cre </span>
   <span class="font10">CDCDFoxP </span>
   <span class="font10">CDd </span>
   <span class="font10">CFC </span>
   <span class="font10">CFU </span>
   <span class="font10">CI= </span>
   <span class="font10">CLIMB </span>
   <span class="font10">CNS-resident </span>
   <span class="font10">COCs </span>
   <span class="font10">CSF-TCL </span>
   <span class="font10">Canadian </span>
   <span class="font10">Caracas, </span>
   <span class="font10">Carlos, </span>
   <span class="font10">Casper </span>
   <span class="font10">Cavalla </span>
   <span class="font10">Cellular </span>
   <span class="font10">Change </span>
   <span class="font10">Chen </span>
   <span class="font10">China, </span>
   <span class="font10">Chinese </span>
   <span class="font10">Coghe </span>
   <span class="font10">Colorado, </span>
   <span class="font10">Columbia </span>
   <span class="font10">Consistent </span>
   <span class="font10">Conventional </span>
   <span class="font10">Correale </span>
   <span class="font10">Course </span>
   <span class="font10">Cunningham </span>
   <span class="font10">Cyt. </span>
   <span class="font10">DCs, </span>
   <span class="font10">DEFINE/CONFIRM </span>
   <span class="font10">Damasceno </span>
   <span class="font10">Danish </span>
   <span class="font10">Determined </span>
   <span class="font10">Drug </span>
   <span class="font10">EBNA- </span>
   <span class="font10">ECM </span>
   <span class="font10">EDSS). </span>
   <span class="font10">EDV </span>
   <span class="font10">EEG </span>
   <span class="font10">EQ-D </span>
   <span class="font10">Echo </span>
   <span class="font10">Elkins </span>
   <span class="font10">Environmental </span>
   <span class="font10">Esposito </span>
   <span class="font10">Evidence </span>
   <span class="font10">Exposure </span>
   <span class="font10">FAST </span>
   <span class="font10">FN, </span>
   <span class="font10">FP, </span>
   <span class="font10">Falini </span>
   <span class="font10">Fampyra </span>
   <span class="font10">Farkas </span>
   <span class="font10">Ferraro </span>
   <span class="font10">Filli </span>
   <span class="font10">Fingolimod, </span>
   <span class="font10">Fit! </span>
   <span class="font10">Frau </span>
   <span class="font10">Function </span>
   <span class="font10">Furthermore </span>
   <span class="font10">GA, </span>
   <span class="font10">GA-treated </span>
   <span class="font10">GEPCI </span>
   <span class="font10">GILZ </span>
   <span class="font10">GM, </span>
   <span class="font10">GM. </span>
   <span class="font10">Genes </span>
   <span class="font10">Giovanni </span>
   <span class="font10">Glanz </span>
   <span class="font10">Glostrup </span>
   <span class="font10">Glostrup, </span>
   <span class="font10">Goettingen, </span>
   <span class="font10">González </span>
   <span class="font10">Goodman </span>
   <span class="font10">Goyang-si, </span>
   <span class="font10">Gradient </span>
   <span class="font10">Greece </span>
   <span class="font10">HCs, </span>
   <span class="font10">HCs. </span>
   <span class="font10">HGF-treated </span>
   <span class="font10">HRQoL. </span>
   <span class="font10">HRT </span>
   <span class="font10">Habek </span>
   <span class="font10">Harris </span>
   <span class="font10">Heidelberg </span>
   <span class="font10">Heine </span>
   <span class="font10">Henry </span>
   <span class="font10">Hierro </span>
   <span class="font10">Hill, </span>
   <span class="font10">Histological </span>
   <span class="font10">Hucke </span>
   <span class="font10">IFN-β </span>
   <span class="font10">IFNβa </span>
   <span class="font10">INSERM </span>
   <span class="font10">IgG. </span>
   <span class="font10">Illumina </span>
   <span class="font10">Ilsan </span>
   <span class="font10">Immunosuppressive </span>
   <span class="font10">Impaired </span>
   <span class="font10">Increasing </span>
   <span class="font10">Index, </span>
   <span class="font10">Individuals </span>
   <span class="font10">Initial </span>
   <span class="font10">Inonu </span>
   <span class="font10">Institut </span>
   <span class="font10">Interferon </span>
   <span class="font10">Intimacy </span>
   <span class="font10">Intrathecal </span>
   <span class="font10">Istituto </span>
   <span class="font10">Item </span>
   <span class="font10">J-M </span>
   <span class="font10">J-P </span>
   <span class="font10">Jager </span>
   <span class="font10">Japanese </span>
   <span class="font10">June </span>
   <span class="font10">Kantar </span>
   <span class="font10">Kapitza </span>
   <span class="font10">Karolinska </span>
   <span class="font10">Kessler </span>
   <span class="font10">Kieseier </span>
   <span class="font10">Killestein </span>
   <span class="font10">Kinematic </span>
   <span class="font10">Kinesiology </span>
   <span class="font10">Klotz </span>
   <span class="font10">Kolind </span>
   <span class="font10">LAQ-treated </span>
   <span class="font10">LSS </span>
   <span class="font10">LWM </span>
   <span class="font10">Langone </span>
   <span class="font10">Laule </span>
   <span class="font10">Lechner-Scott </span>
   <span class="font10">Leocani </span>
   <span class="font10">Leppert </span>
   <span class="font10">Linda, </span>
   <span class="font10">Los </span>
   <span class="font10">Lotze </span>
   <span class="font10">Ltd, </span>
   <span class="font10">Ludwig-Maximilians-University, </span>
   <span class="font10">Lugano, </span>
   <span class="font10">Lugaresi </span>
   <span class="font10">Lörincz </span>
   <span class="font10">MADRS </span>
   <span class="font10">MANOVA </span>
   <span class="font10">MAS </span>
   <span class="font10">MC, </span>
   <span class="font10">MMF </span>
   <span class="font10">MN, </span>
   <span class="font10">MS-patients </span>
   <span class="font10">MSBase </span>
   <span class="font10">MSMC </span>
   <span class="font10">MSWS-/IT </span>
   <span class="font10">Malatya, </span>
   <span class="font10">Marmara </span>
   <span class="font10">Mary </span>
   <span class="font10">Materials </span>
   <span class="font10">Mechanical, </span>
   <span class="font10">MedImmune, </span>
   <span class="font10">Mehta </span>
   <span class="font10">Merck </span>
   <span class="font10">MicroRNA </span>
   <span class="font10">Milwaukee, </span>
   <span class="font10">Multifocal </span>
   <span class="font10">Mycko </span>
   <span class="font10">Myelin </span>
   <span class="font10">NDC-, </span>
   <span class="font10">NDO </span>
   <span class="font10">Nat </span>
   <span class="font10">Network, </span>
   <span class="font10">NeuN </span>
   <span class="font10">Neurol </span>
   <span class="font10">Neuronal </span>
   <span class="font10">Nineteen </span>
   <span class="font10">Nintendo </span>
   <span class="font10">Nottingham, </span>
   <span class="font10">Novartis </span>
   <span class="font10">Nur-deficient </span>
   <span class="font10">Nutritional </span>
   <span class="font10">ONH </span>
   <span class="font10">Ophthalmology, </span>
   <span class="font10">Ottawa </span>
   <span class="font10">Ottawa, </span>
   <span class="font10">PA-RT-PCR </span>
   <span class="font10">PCR. </span>
   <span class="font10">PDCs </span>
   <span class="font10">PPMS. </span>
   <span class="font10">PR-Fampridine </span>
   <span class="font10">PRISMS </span>
   <span class="font10">Paediatric </span>
   <span class="font10">Paradigm </span>
   <span class="font10">Pareto </span>
   <span class="font10">Park, </span>
   <span class="font10">Pathological </span>
   <span class="font10">Pau </span>
   <span class="font10">Ped-MS </span>
   <span class="font10">Pediatrics, </span>
   <span class="font10">Pereira </span>
   <span class="font10">Perfusion </span>
   <span class="font10">Pgp </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Pharmacological </span>
   <span class="font10">Phoenix, </span>
   <span class="font10">Physiology, </span>
   <span class="font10">Planchon </span>
   <span class="font10">Portuguese </span>
   <span class="font10">Potential </span>
   <span class="font10">Presence </span>
   <span class="font10">Preston, </span>
   <span class="font10">Proportion </span>
   <span class="font10">Psychiatric </span>
   <span class="font10">PwMS. </span>
   <span class="font10">Pérez-Miralles </span>
   <span class="font10">QOL. </span>
   <span class="font10">QSI </span>
   <span class="font10">QTc </span>
   <span class="font10">QoL. </span>
   <span class="font10">Questionnaire- </span>
   <span class="font10">RAGE </span>
   <span class="font10">Recurrent </span>
   <span class="font10">Reduction </span>
   <span class="font10">Referring </span>
   <span class="font10">Register </span>
   <span class="font10">Repeat </span>
   <span class="font10">Reproductive </span>
   <span class="font10">Reserve </span>
   <span class="font10">Respondents </span>
   <span class="font10">Rigshospitalet, </span>
   <span class="font10">Roche </span>
   <span class="font10">Roche, </span>
   <span class="font10">Rostock, </span>
   <span class="font10">Ruhr-University </span>
   <span class="font10">Río </span>
   <span class="font10">SNR </span>
   <span class="font10">SVM </span>
   <span class="font10">Sackler </span>
   <span class="font10">Saint </span>
   <span class="font10">Saiz </span>
   <span class="font10">Sastre-Garriga </span>
   <span class="font10">Sati </span>
   <span class="font10">Scler </span>
   <span class="font10">Segmentation </span>
   <span class="font10">Seneca </span>
   <span class="font10">Service, </span>
   <span class="font10">Shanghai, </span>
   <span class="font10">Siemens </span>
   <span class="font10">Silva </span>
   <span class="font10">Single </span>
   <span class="font10">Sleep </span>
   <span class="font10">Smith </span>
   <span class="font10">Society, </span>
   <span class="font10">Sormani </span>
   <span class="font10">Spanish </span>
   <span class="font10">Special </span>
   <span class="font10">Spectralis </span>
   <span class="font10">Steps </span>
   <span class="font10">Student’s </span>
   <span class="font10">Sutter </span>
   <span class="font10">Symptom </span>
   <span class="font10">T-cells, </span>
   <span class="font10">T-w </span>
   <span class="font10">TGFβ </span>
   <span class="font10">TN, </span>
   <span class="font10">TNFR </span>
   <span class="font10">Technology, </span>
   <span class="font10">Tedeschi </span>
   <span class="font10">Tehran </span>
   <span class="font10">Teriflunomide </span>
   <span class="font10">ThTh </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">Thirty </span>
   <span class="font10">Tillema </span>
   <span class="font10">Time </span>
   <span class="font10">Tomography </span>
   <span class="font10">Tregs, </span>
   <span class="font10">Trojano </span>
   <span class="font10">Tropical </span>
   <span class="font10">Trp </span>
   <span class="font10">Twenty-five </span>
   <span class="font10">UCSF </span>
   <span class="font10">UK. </span>
   <span class="font10">Urbana, </span>
   <span class="font10">Urinary </span>
   <span class="font10">VEP-tr </span>
   <span class="font10">Vartanian </span>
   <span class="font10">Verona, </span>
   <span class="font10">Vitetta </span>
   <span class="font10">WHODAS-II </span>
   <span class="font10">WML, </span>
   <span class="font10">WMVc% </span>
   <span class="font10">Wattjes </span>
   <span class="font10">Weller </span>
   <span class="font10">Wiendl </span>
   <span class="font10">Wiggermann </span>
   <span class="font10">Williams </span>
   <span class="font10">Wills </span>
   <span class="font10">Yonsei </span>
   <span class="font10">Zimmermann </span>
   <span class="font10">Zörner </span>
   <span class="font10">[.; </span>
   <span class="font10">[SD] </span>
   <span class="font10">abnormalities. </span>
   <span class="font10">abnormality </span>
   <span class="font10">accelerated </span>
   <span class="font10">acceleration </span>
   <span class="font10">accounted </span>
   <span class="font10">accounting </span>
   <span class="font10">acetate, </span>
   <span class="font10">acts </span>
   <span class="font10">additionally </span>
   <span class="font10">agonist, </span>
   <span class="font10">alSacEP </span>
   <span class="font10">alignment </span>
   <span class="font10">ambulation </span>
   <span class="font10">animals. </span>
   <span class="font10">annually </span>
   <span class="font10">annually. </span>
   <span class="font10">answers </span>
   <span class="font10">antagonists </span>
   <span class="font10">anti-CD </span>
   <span class="font10">antigen-presenting </span>
   <span class="font10">antinuclear </span>
   <span class="font10">apart. </span>
   <span class="font10">applicable </span>
   <span class="font10">architecture </span>
   <span class="font10">area. </span>
   <span class="font10">array </span>
   <span class="font10">arrhythmias </span>
   <span class="font10">artery </span>
   <span class="font10">articles </span>
   <span class="font10">assays, </span>
   <span class="font10">assumptions </span>
   <span class="font10">astrocytes, </span>
   <span class="font10">astrocytic </span>
   <span class="font10">attack. </span>
   <span class="font10">attainment </span>
   <span class="font10">attention, </span>
   <span class="font10">attributed </span>
   <span class="font10">atypical </span>
   <span class="font10">autoantibody </span>
   <span class="font10">automatic </span>
   <span class="font10">axon </span>
   <span class="font10">bacterial </span>
   <span class="font10">balance, </span>
   <span class="font10">balance. </span>
   <span class="font10">behaviors, </span>
   <span class="font10">believed </span>
   <span class="font10">blog </span>
   <span class="font10">blue </span>
   <span class="font10">bold </span>
   <span class="font10">bound </span>
   <span class="font10">boys) </span>
   <span class="font10">brainstem. </span>
   <span class="font10">breast </span>
   <span class="font10">built </span>
   <span class="font10">cKO </span>
   <span class="font10">candidate </span>
   <span class="font10">candidates </span>
   <span class="font10">capacity, </span>
   <span class="font10">carcinoma </span>
   <span class="font10">cardiac </span>
   <span class="font10">carotid </span>
   <span class="font10">cascade </span>
   <span class="font10">catabolism </span>
   <span class="font10">categories </span>
   <span class="font10">categorized </span>
   <span class="font10">category </span>
   <span class="font10">caudate </span>
   <span class="font10">cell, </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">challenges </span>
   <span class="font10">characterised </span>
   <span class="font10">child </span>
   <span class="font10">cholecalciferol </span>
   <span class="font10">cholesterol, </span>
   <span class="font10">chromatography </span>
   <span class="font10">clones </span>
   <span class="font10">close </span>
   <span class="font10">co-registered </span>
   <span class="font10">coefficient. </span>
   <span class="font10">cognition, </span>
   <span class="font10">coil </span>
   <span class="font10">collaboration </span>
   <span class="font10">commercial </span>
   <span class="font10">compatible </span>
   <span class="font10">complementary </span>
   <span class="font10">composed </span>
   <span class="font10">concomitant </span>
   <span class="font10">conference. </span>
   <span class="font10">confirming </span>
   <span class="font10">confounding </span>
   <span class="font10">connected </span>
   <span class="font10">connections </span>
   <span class="font10">consequence </span>
   <span class="font10">consequences </span>
   <span class="font10">consider </span>
   <span class="font10">contact </span>
   <span class="font10">contraceptives </span>
   <span class="font10">contrary, </span>
   <span class="font10">contributing </span>
   <span class="font10">control, </span>
   <span class="font10">controls) </span>
   <span class="font10">controls: </span>
   <span class="font10">controversial </span>
   <span class="font10">converted </span>
   <span class="font10">correcting </span>
   <span class="font10">cortex. </span>
   <span class="font10">cortices, </span>
   <span class="font10">counterparts. </span>
   <span class="font10">courier; </span>
   <span class="font10">courses </span>
   <span class="font10">criteria), </span>
   <span class="font10">cross </span>
   <span class="font10">cross-over </span>
   <span class="font10">culture. </span>
   <span class="font10">cultures. </span>
   <span class="font10">cynomolgus </span>
   <span class="font10">cytometry, </span>
   <span class="font10">daily. </span>
   <span class="font10">damages </span>
   <span class="font10">database. </span>
   <span class="font10">dataset </span>
   <span class="font10">de- </span>
   <span class="font10">deceleration </span>
   <span class="font10">decrement </span>
   <span class="font10">default </span>
   <span class="font10">defect </span>
   <span class="font10">defining </span>
   <span class="font10">definitive </span>
   <span class="font10">degeneration. </span>
   <span class="font10">delivery </span>
   <span class="font10">delivery. </span>
   <span class="font10">demonstrating </span>
   <span class="font10">depth </span>
   <span class="font10">descriptive </span>
   <span class="font10">detectable </span>
   <span class="font10">determined. </span>
   <span class="font10">development, </span>
   <span class="font10">deviations </span>
   <span class="font10">differentiating </span>
   <span class="font10">differently </span>
   <span class="font10">difficulties </span>
   <span class="font10">diffusely </span>
   <span class="font10">diminished </span>
   <span class="font10">dipolar </span>
   <span class="font10">dipole </span>
   <span class="font10">discovered </span>
   <span class="font10">discovery </span>
   <span class="font10">discriminative </span>
   <span class="font10">discussion </span>
   <span class="font10">disease-specific </span>
   <span class="font10">disorder. </span>
   <span class="font10">displacements </span>
   <span class="font10">disruption. </span>
   <span class="font10">distal </span>
   <span class="font10">distribution-based </span>
   <span class="font10">disturbance </span>
   <span class="font10">diurnal </span>
   <span class="font10">domains. </span>
   <span class="font10">donor </span>
   <span class="font10">dose, </span>
   <span class="font10">dose-dependent </span>
   <span class="font10">dose. </span>
   <span class="font10">doses, </span>
   <span class="font10">double-blind </span>
   <span class="font10">downregulation </span>
   <span class="font10">downstream </span>
   <span class="font10">dramatically </span>
   <span class="font10">driven </span>
   <span class="font10">drug. </span>
   <span class="font10">dual-echo </span>
   <span class="font10">e.g. </span>
   <span class="font10">edema </span>
   <span class="font10">efficient </span>
   <span class="font10">effort </span>
   <span class="font10">elicited </span>
   <span class="font10">em; </span>
   <span class="font10">emerged </span>
   <span class="font10">emission </span>
   <span class="font10">emotions </span>
   <span class="font10">encoding </span>
   <span class="font10">encountered </span>
   <span class="font10">enrichment </span>
   <span class="font10">enrolled, </span>
   <span class="font10">entered </span>
   <span class="font10">entire </span>
   <span class="font10">enzyme </span>
   <span class="font10">epitopes </span>
   <span class="font10">established. </span>
   <span class="font10">establishing </span>
   <span class="font10">evaluations </span>
   <span class="font10">everyday </span>
   <span class="font10">evidence-based </span>
   <span class="font10">evidences </span>
   <span class="font10">ex-vivo </span>
   <span class="font10">exacerbations </span>
   <span class="font10">examined. </span>
   <span class="font10">execution </span>
   <span class="font10">executive </span>
   <span class="font10">existing </span>
   <span class="font10">experiments, </span>
   <span class="font10">exploratory </span>
   <span class="font10">external </span>
   <span class="font10">extract </span>
   <span class="font10">eyes) </span>
   <span class="font10">facial </span>
   <span class="font10">factor, </span>
   <span class="font10">failed </span>
   <span class="font10">fampridine-SR </span>
   <span class="font10">fampridine. </span>
   <span class="font10">far. </span>
   <span class="font10">favor </span>
   <span class="font10">fearful </span>
   <span class="font10">feasibility </span>
   <span class="font10">fed </span>
   <span class="font10">feeding. </span>
   <span class="font10">feel </span>
   <span class="font10">feet </span>
   <span class="font10">fifth </span>
   <span class="font10">filling </span>
   <span class="font10">flexor </span>
   <span class="font10">form, </span>
   <span class="font10">fragilis </span>
   <span class="font10">french </span>
   <span class="font10">fulfilled </span>
   <span class="font10">future. </span>
   <span class="font10">gait, </span>
   <span class="font10">gait. </span>
   <span class="font10">game </span>
   <span class="font10">gender. </span>
   <span class="font10">genomic </span>
   <span class="font10">gestational </span>
   <span class="font10">glutamine </span>
   <span class="font10">graph </span>
   <span class="font10">group). </span>
   <span class="font10">group: </span>
   <span class="font10">guided </span>
   <span class="font10">hand, </span>
   <span class="font10">hazard </span>
   <span class="font10">hemodynamic </span>
   <span class="font10">hippocampi </span>
   <span class="font10">hippocampus. </span>
   <span class="font10">hits </span>
   <span class="font10">hope </span>
   <span class="font10">hormonal </span>
   <span class="font10">hubs </span>
   <span class="font10">hyperintense </span>
   <span class="font10">ideal </span>
   <span class="font10">illness. </span>
   <span class="font10">imagery </span>
   <span class="font10">imaging, </span>
   <span class="font10">imbalance </span>
   <span class="font10">immediate </span>
   <span class="font10">immunofluorescence </span>
   <span class="font10">immunohistochemical </span>
   <span class="font10">immunohistochemically </span>
   <span class="font10">immunohistochemistry, </span>
   <span class="font10">impacted </span>
   <span class="font10">implication </span>
   <span class="font10">incident </span>
   <span class="font10">incorporating </span>
   <span class="font10">index, </span>
   <span class="font10">indicative </span>
   <span class="font10">infection, </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">information, </span>
   <span class="font10">information. </span>
   <span class="font10">inhibit </span>
   <span class="font10">injury. </span>
   <span class="font10">input </span>
   <span class="font10">instability </span>
   <span class="font10">instead </span>
   <span class="font10">instrument </span>
   <span class="font10">insufficiency </span>
   <span class="font10">intact. </span>
   <span class="font10">intake </span>
   <span class="font10">interleukin- </span>
   <span class="font10">international </span>
   <span class="font10">interview </span>
   <span class="font10">interviewed </span>
   <span class="font10">intestinal </span>
   <span class="font10">intramuscular </span>
   <span class="font10">involve </span>
   <span class="font10">ischemic </span>
   <span class="font10">keeping </span>
   <span class="font10">leg </span>
   <span class="font10">licensed </span>
   <span class="font10">likelihood </span>
   <span class="font10">limitation </span>
   <span class="font10">line) </span>
   <span class="font10">lineage </span>
   <span class="font10">lines </span>
   <span class="font10">lipids </span>
   <span class="font10">literature, </span>
   <span class="font10">literature. </span>
   <span class="font10">load. </span>
   <span class="font10">low-normal </span>
   <span class="font10">lytic </span>
   <span class="font10">mDC </span>
   <span class="font10">magnetization </span>
   <span class="font10">magnitude </span>
   <span class="font10">man </span>
   <span class="font10">manageable </span>
   <span class="font10">managed </span>
   <span class="font10">manipulation </span>
   <span class="font10">manner. </span>
   <span class="font10">markers, </span>
   <span class="font10">markers. </span>
   <span class="font10">mean(SD) </span>
   <span class="font10">meaningful </span>
   <span class="font10">measure, </span>
   <span class="font10">measurement. </span>
   <span class="font10">mechanistic </span>
   <span class="font10">mediating </span>
   <span class="font10">mediation </span>
   <span class="font10">mediators </span>
   <span class="font10">meeting </span>
   <span class="font10">memantine </span>
   <span class="font10">member </span>
   <span class="font10">members </span>
   <span class="font10">meninges </span>
   <span class="font10">menopause. </span>
   <span class="font10">methylprednisolone, </span>
   <span class="font10">mfERG </span>
   <span class="font10">microglia, </span>
   <span class="font10">microscopy. </span>
   <span class="font10">migraine </span>
   <span class="font10">modest </span>
   <span class="font10">modulated </span>
   <span class="font10">modulates </span>
   <span class="font10">module </span>
   <span class="font10">monitoring. </span>
   <span class="font10">monocular </span>
   <span class="font10">month. </span>
   <span class="font10">months) </span>
   <span class="font10">months), </span>
   <span class="font10">ms, </span>
   <span class="font10">multidimensional </span>
   <span class="font10">myelinated </span>
   <span class="font10">natalizumab-induced </span>
   <span class="font10">naïve, </span>
   <span class="font10">nearly </span>
   <span class="font10">neuro-modulatory </span>
   <span class="font10">neurodegeneration. </span>
   <span class="font10">neurofilament </span>
   <span class="font10">neurogenic </span>
   <span class="font10">neuroinflammatory </span>
   <span class="font10">neuromotor </span>
   <span class="font10">neuropathic </span>
   <span class="font10">neuropathology </span>
   <span class="font10">neuroradiologist </span>
   <span class="font10">neuroticism </span>
   <span class="font10">neurotrophins </span>
   <span class="font10">newborns </span>
   <span class="font10">nmol/L </span>
   <span class="font10">non-fatigued </span>
   <span class="font10">non-significant </span>
   <span class="font10">normal-IgG </span>
   <span class="font10">normalization </span>
   <span class="font10">numerical </span>
   <span class="font10">obvious </span>
   <span class="font10">ocrelizumab </span>
   <span class="font10">one’s </span>
   <span class="font10">ongoing. </span>
   <span class="font10">operating </span>
   <span class="font10">orientation </span>
   <span class="font10">out. </span>
   <span class="font10">overexpression </span>
   <span class="font10">oxysterols </span>
   <span class="font10">p=,). </span>
   <span class="font10">page </span>
   <span class="font10">papers </span>
   <span class="font10">paradigm </span>
   <span class="font10">parameters: </span>
   <span class="font10">parcellation </span>
   <span class="font10">parental </span>
   <span class="font10">parents </span>
   <span class="font10">parietal </span>
   <span class="font10">participants. </span>
   <span class="font10">partly </span>
   <span class="font10">passage </span>
   <span class="font10">pathogenesis. </span>
   <span class="font10">pathophysiological </span>
   <span class="font10">patients). </span>
   <span class="font10">percentile </span>
   <span class="font10">perceptions </span>
   <span class="font10">perfringens </span>
   <span class="font10">phone </span>
   <span class="font10">physician </span>
   <span class="font10">placebo, </span>
   <span class="font10">platforms </span>
   <span class="font10">played </span>
   <span class="font10">plexiform </span>
   <span class="font10">polarization </span>
   <span class="font10">positron </span>
   <span class="font10">possess </span>
   <span class="font10">postnatal </span>
   <span class="font10">potential, </span>
   <span class="font10">preceding </span>
   <span class="font10">presentations </span>
   <span class="font10">pressure </span>
   <span class="font10">prevalance </span>
   <span class="font10">prevented </span>
   <span class="font10">prevention </span>
   <span class="font10">principal </span>
   <span class="font10">probe </span>
   <span class="font10">production. </span>
   <span class="font10">professionals </span>
   <span class="font10">profound </span>
   <span class="font10">program, </span>
   <span class="font10">progressive, </span>
   <span class="font10">prompt </span>
   <span class="font10">prone </span>
   <span class="font10">pronounced </span>
   <span class="font10">protected </span>
   <span class="font10">pt;} </span>
   <span class="font10">puberty. </span>
   <span class="font10">pure </span>
   <span class="font10">putamen </span>
   <span class="font10">pwMS. </span>
   <span class="font10">pyramidal </span>
   <span class="font10">quantitatively </span>
   <span class="font10">questions </span>
   <span class="font10">radiologically </span>
   <span class="font10">ranked </span>
   <span class="font10">rate. </span>
   <span class="font10">rating </span>
   <span class="font10">ratings </span>
   <span class="font10">raw </span>
   <span class="font10">real-time </span>
   <span class="font10">reasonable </span>
   <span class="font10">recovery. </span>
   <span class="font10">refers </span>
   <span class="font10">regimen </span>
   <span class="font10">relapsed </span>
   <span class="font10">relations </span>
   <span class="font10">relationships, </span>
   <span class="font10">removal </span>
   <span class="font10">remyelination, </span>
   <span class="font10">replicate </span>
   <span class="font10">reproducible </span>
   <span class="font10">rescue </span>
   <span class="font10">research. </span>
   <span class="font10">restricted </span>
   <span class="font10">retained </span>
   <span class="font10">retroviral </span>
   <span class="font10">rs-fMRI </span>
   <span class="font10">sNRS </span>
   <span class="font10">sacrificed </span>
   <span class="font10">sample, </span>
   <span class="font10">sample. </span>
   <span class="font10">scale, </span>
   <span class="font10">scales, </span>
   <span class="font10">scanner </span>
   <span class="font10">scores, </span>
   <span class="font10">secretion. </span>
   <span class="font10">selective, </span>
   <span class="font10">self-management </span>
   <span class="font10">sensory-motor </span>
   <span class="font10">separately </span>
   <span class="font10">serves </span>
   <span class="font10">session </span>
   <span class="font10">sessions. </span>
   <span class="font10">sheath </span>
   <span class="font10">shell </span>
   <span class="font10">shell-like </span>
   <span class="font10">signature </span>
   <span class="font10">signify </span>
   <span class="font10">silencing </span>
   <span class="font10">similarly </span>
   <span class="font10">simulations </span>
   <span class="font10">sites. </span>
   <span class="font10">slanDC, </span>
   <span class="font10">slices </span>
   <span class="font10">slope </span>
   <span class="font10">sodium </span>
   <span class="font10">space. </span>
   <span class="font10">specialized </span>
   <span class="font10">specimens </span>
   <span class="font10">spectroscopic </span>
   <span class="font10">speed. </span>
   <span class="font10">sphingosine--phosphate </span>
   <span class="font10">stability, </span>
   <span class="font10">staging </span>
   <span class="font10">stimulate </span>
   <span class="font10">stool </span>
   <span class="font10">stop </span>
   <span class="font10">studies), </span>
   <span class="font10">subject’s </span>
   <span class="font10">summary </span>
   <span class="font10">supernatant </span>
   <span class="font10">support, </span>
   <span class="font10">suppressing </span>
   <span class="font10">surgical </span>
   <span class="font10">surrounding </span>
   <span class="font10">syndrome. </span>
   <span class="font10">synthetic </span>
   <span class="font10">tCr </span>
   <span class="font10">tablet </span>
   <span class="font10">targeted </span>
   <span class="font10">tasks. </span>
   <span class="font10">team </span>
   <span class="font10">technique, </span>
   <span class="font10">technique. </span>
   <span class="font10">teriflunomide. </span>
   <span class="font10">terminal </span>
   <span class="font10">tests, </span>
   <span class="font10">thalamic </span>
   <span class="font10">thicknesses </span>
   <span class="font10">thymus </span>
   <span class="font10">time-consuming </span>
   <span class="font10">timing </span>
   <span class="font10">titres </span>
   <span class="font10">to: </span>
   <span class="font10">took </span>
   <span class="font10">topic </span>
   <span class="font10">topology </span>
   <span class="font10">total, </span>
   <span class="font10">toxicity </span>
   <span class="font10">track </span>
   <span class="font10">trafficking </span>
   <span class="font10">training. </span>
   <span class="font10">transgenic </span>
   <span class="font10">translational </span>
   <span class="font10">transporters </span>
   <span class="font10">treatment). </span>
   <span class="font10">treatment-naïve </span>
   <span class="font10">tremor, </span>
   <span class="font10">tremor/coordination </span>
   <span class="font10">two-years </span>
   <span class="font10">uncommon </span>
   <span class="font10">und </span>
   <span class="font10">understood, </span>
   <span class="font10">unexposed </span>
   <span class="font10">unilateral </span>
   <span class="font10">units </span>
   <span class="font10">unpaired </span>
   <span class="font10">up-regulated </span>
   <span class="font10">upright </span>
   <span class="font10">use, </span>
   <span class="font10">use. </span>
   <span class="font10">used, </span>
   <span class="font10">value. </span>
   <span class="font10">values. </span>
   <span class="font10">variability, </span>
   <span class="font10">variables) </span>
   <span class="font10">verify </span>
   <span class="font10">viable </span>
   <span class="font10">viral </span>
   <span class="font10">visible </span>
   <span class="font10">visualization </span>
   <span class="font10">visually </span>
   <span class="font10">vivo, </span>
   <span class="font10">volumes, </span>
   <span class="font10">voxelwise </span>
   <span class="font10">vulnerable </span>
   <span class="font10">walking. </span>
   <span class="font10">weak </span>
   <span class="font10">webinar </span>
   <span class="font10">well. </span>
   <span class="font10">whilst </span>
   <span class="font10">white, </span>
   <span class="font10">widening </span>
   <span class="font10">wider </span>
   <span class="font10">withdrawal. </span>
   <span class="font10">worsening, </span>
   <span class="font10">younger </span>
   <span class="font10">αL/ß </span>
  </p>
 </body>
</html>
